var title_f13_56_14208="RB ILD PA";
var content_f13_56_14208=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F59288&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F59288&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Respiratory bronchiolitis-associated interstitial lung disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior roentgenogram of the chest showing diffuse reticulonodular opacities most prominent in the lower lung zones in a heavy smoker with chronic cough and exertional dyspnea of six months' duration.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Talmadge E King, Jr MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14208=[""].join("\n");
var outline_f13_56_14208=null;
var title_f13_56_14209="Japanese encephalitis virus vaccine (inactivated): Patient drug information";
var content_f13_56_14209=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Japanese encephalitis virus vaccine (inactivated): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/38/40549?source=see_link\">",
"     see \"Japanese encephalitis virus vaccine (inactivated): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/53/43860?source=see_link\">",
"     see \"Japanese encephalitis virus vaccine (inactivated): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F185565\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ixiaro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F13495796\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ixiaro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt adi-os drugH1Div\" id=\"F10031430\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     CDC Information",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Vaccine Information Statements (VIS) are made by the staff of the Centers for Disease Control and Prevention (CDC). Each VIS gives information to properly inform the adult receiving the vaccine or, in the case of a minor, the child's parent or legal representative about the risks and benefits of each vaccine. Before a doctor vaccinates a child or an adult, the provider is required by the National Childhood Vaccine Injury Act to give a copy of the VIS. You can also get foreign language versions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705996",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <a href=\"file://www.immunize.org/vis/vis_japanese_encephalitis_ixiaro.asp\" target=\"_blank\">",
"        Vaccine Information Statements (VIS)",
"       </a>",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11791 Version 29.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-FC043B0C43-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14209=[""].join("\n");
var outline_f13_56_14209=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F185565\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13495796\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031430\">",
"      CDC Information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?39/38/40549?source=related_link\">",
"      Japanese encephalitis virus vaccine (inactivated): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?42/53/43860?source=related_link\">",
"      Japanese encephalitis virus vaccine (inactivated): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_56_14210="Rape";
var content_f13_56_14210=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F50009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F50009&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Traumatic rape of child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 340px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Injury unable to be assessed without sedation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marc R. Laufer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14210=[""].join("\n");
var outline_f13_56_14210=null;
var title_f13_56_14211="Patient information: Choosing birth control (The Basics)";
var content_f13_56_14211=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15349\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/50/3876\">",
"         How pregnancy happens",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/16/33032\">",
"          How effective are the different forms of birth control?",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_table\" href=\"UTD.htm?17/15/17660\">",
"           Types of birth control",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?12/28/12738\">",
"         Patient information: Emergency contraception (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/17/18707\">",
"         Patient information: Hormonal birth control (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/17/37138\">",
"         Patient information: Intrauterine devices (IUD) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?1/22/1378\">",
"         Patient information: Long-acting methods of birth control (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?22/51/23346\">",
"         Patient information: Sterilization for women (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/25/36242\">",
"         Patient information: Vasectomy (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?22/2/22563\">",
"         Patient information: Barrier methods of birth control (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?8/60/9157\">",
"         Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/32/22021\">",
"         Patient information: Hormonal methods of birth control (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?4/16/4355\">",
"         Patient information: Long-term methods of birth control (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/28/7620\">",
"         Patient information: Permanent sterilization procedures for women (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/2/29730\">",
"         Patient information: Vasectomy (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Choosing birth control (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/choosing-birth-control-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H46966067\">",
"      <span class=\"h1\">",
"       What is birth control?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Birth control is a term used to describe ways to prevent pregnancy. Another word for birth control is &ldquo;contraception.&rdquo;",
"     </p>",
"     <p>",
"      Different types of birth control include medicines, devices, and procedures. Some types of birth control are used by women, and others are used by men. Some types need to be used every time a person has sex. Other types can prevent pregnancy for long periods of time. Some types need a doctor&rsquo;s prescription, and others do not.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46966074\">",
"      <span class=\"h1\">",
"       Which type of birth control should I choose?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Choosing birth control can be tough, because no birth control is perfect. Your doctor or nurse can help you choose the type that is right for you. To help you make a decision, think about:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        How well it prevents pregnancy &ndash; No birth control works 100 percent perfectly all the time, but some prevent pregnancy better than others.",
"       </li>",
"       <li>",
"        How often you have to use it &ndash; For example, women who use birth control pills must take them every day.",
"       </li>",
"       <li>",
"        How easy it is to use",
"       </li>",
"       <li>",
"        Its side effects or downsides",
"       </li>",
"       <li>",
"        Its cost",
"       </li>",
"       <li>",
"        If you want to get pregnant in the future &ndash; Some types of birth control are permanent, meaning they prevent you from ever getting pregnant. Other types of birth control prevent pregnancy only for a limited amount of time. After that time, you can still get pregnant. &nbsp;",
"       </li>",
"       <li>",
"        Whether it protects you from infection &ndash; Only male and female condoms can reduce your chance of getting certain infections called &ldquo;STDs&rdquo; (or sexually transmitted diseases).",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46966081\">",
"      <span class=\"h1\">",
"       What are the different types of birth control and how do they work?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Different types of birth control prevent pregnancy in different ways and have different levels of effectiveness (",
"      <a class=\"graphic graphic_figure graphicRef73238 \" href=\"UTD.htm?3/50/3876\">",
"       figure 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef88535 \" href=\"UTD.htm?32/16/33032\">",
"       figure 2",
"      </a>",
"      ). Each of the main types is discussed in more detail elsewhere (",
"      <a class=\"graphic graphic_table graphicRef88695 \" href=\"UTD.htm?17/15/17660\">",
"       table 1",
"      </a>",
"      ). See:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <a class=\"medical medical_basics\" href=\"UTD.htm?18/17/18707?source=see_link\">",
"         Patient information: Hormonal birth control (The Basics)",
"        </a>",
"       </li>",
"       <li>",
"        <a class=\"medical medical_basics\" href=\"UTD.htm?36/17/37138?source=see_link\">",
"         Patient information: Intrauterine devices (IUD) (The Basics)",
"        </a>",
"       </li>",
"       <li>",
"        <a class=\"medical medical_basics\" href=\"UTD.htm?1/22/1378?source=see_link\">",
"         Patient information: Long-acting methods of birth control (The Basics)",
"        </a>",
"       </li>",
"       <li>",
"        <a class=\"medical medical_basics\" href=\"UTD.htm?12/28/12738?source=see_link\">",
"         Patient information: Emergency contraception (The Basics)",
"        </a>",
"       </li>",
"       <li>",
"        <a class=\"medical medical_basics\" href=\"UTD.htm?22/51/23346?source=see_link\">",
"         Patient information: Sterilization for women (The Basics)",
"        </a>",
"       </li>",
"       <li>",
"        <a class=\"medical medical_basics\" href=\"UTD.htm?35/25/36242?source=see_link\">",
"         Patient information: Vasectomy (The Basics)",
"        </a>",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H5745320\">",
"      <span class=\"h1\">",
"       What about natural forms of birth control?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There are a few forms of &ldquo;natural&rdquo; birth control, which require no medicines or devices. But they are not as effective as the other forms of birth control. Natural birth control methods include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Withdrawal &ndash; This is when the man pulls out before he ejaculates.",
"       </li>",
"       <li>",
"        Fertility awareness &ndash; This is when the woman keeps track of her menstrual cycle so she can predict when she is most likely to get pregnant. Then, she avoids sex during that time, or uses some form of birth control then, such as a condom.",
"       </li>",
"       <li>",
"        Breastfeeding &ndash; Breastfeeding can decrease a woman&rsquo;s ability to get pregnant. Some women use it as a form of birth control for the first few weeks after a baby is born. But for it to work, breast milk should be the baby&rsquo;s only food. The medical term for this method is &ldquo;lactational amenorrhea method,&rdquo; or &ldquo;LAM.&rdquo; If you decide to try this method, discuss it with your doctor or nurse.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46966088\">",
"      <span class=\"h1\">",
"       What if I have problems with my birth control?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Let your doctor or nurse know if you have any side effects or problems with your birth control. Sometimes, side effects will go away after a few months. If they don&rsquo;t, you might need to work with your doctor or nurse to find a different type of birth control.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H46966151\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/17/18707?source=see_link\">",
"       Patient information: Hormonal birth control (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/17/37138?source=see_link\">",
"       Patient information: Intrauterine devices (IUD) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?1/22/1378?source=see_link\">",
"       Patient information: Long-acting methods of birth control (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?12/28/12738?source=see_link\">",
"       Patient information: Emergency contraception (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?22/51/23346?source=see_link\">",
"       Patient information: Sterilization for women (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/25/36242?source=see_link\">",
"       Patient information: Vasectomy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=see_link\">",
"       Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?21/32/22021?source=see_link\">",
"       Patient information: Hormonal methods of birth control (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/2/22563?source=see_link\">",
"       Patient information: Barrier methods of birth control (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?4/16/4355?source=see_link\">",
"       Patient information: Long-term methods of birth control (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/2/29730?source=see_link\">",
"       Patient information: Vasectomy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/28/7620?source=see_link\">",
"       Patient information: Permanent sterilization procedures for women (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?13/56/14211?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15349 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-CACC98E3A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14211=[""].join("\n");
var outline_f13_56_14211=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46966067\">",
"      What is birth control?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46966074\">",
"      Which type of birth control should I choose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46966081\">",
"      What are the different types of birth control and how do they work?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5745320\">",
"      What about natural forms of birth control?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46966088\">",
"      What if I have problems with my birth control?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46966151\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15349\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/50/3876\">",
"      How pregnancy happens",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/16/33032\">",
"       How effective are the different forms of birth control?",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_table\" href=\"UTD.htm?17/15/17660\">",
"        Types of birth control",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/2/22563?source=related_link\">",
"      Patient information: Barrier methods of birth control (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=related_link\">",
"      Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?12/28/12738?source=related_link\">",
"      Patient information: Emergency contraception (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/17/18707?source=related_link\">",
"      Patient information: Hormonal birth control (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/32/22021?source=related_link\">",
"      Patient information: Hormonal methods of birth control (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/17/37138?source=related_link\">",
"      Patient information: Intrauterine devices (IUD) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?1/22/1378?source=related_link\">",
"      Patient information: Long-acting methods of birth control (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?4/16/4355?source=related_link\">",
"      Patient information: Long-term methods of birth control (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/28/7620?source=related_link\">",
"      Patient information: Permanent sterilization procedures for women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?22/51/23346?source=related_link\">",
"      Patient information: Sterilization for women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/2/29730?source=related_link\">",
"      Patient information: Vasectomy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/25/36242?source=related_link\">",
"      Patient information: Vasectomy (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_56_14212="Alitretinoin: Patient drug information";
var content_f13_56_14212=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Alitretinoin: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/45/25299?source=see_link\">",
"     see \"Alitretinoin: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F131672\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Panretin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F16369036\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Toctino",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692078",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin wounds in patients with AIDS-related Kaposi's sarcoma.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691248",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It may take 3 months to see the full effect.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701464",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to alitretinoin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696748",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not donate blood while using this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696948",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use this drug with insect repellents that have N, N-diethyl-m-toluamide (DEET).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696682",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid other sources of vitamin A.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696817",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use coverings (bandages, dressings, make-up) unless told to do so by your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust 1 month before care starts, during care, and for at least 1 month after care ends.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694772",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug by mouth. Use on your skin only. Keep out of your mouth, nose, and eyes (may burn).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696257",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wash your hands before and after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694623",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Clean affected part before use. Make sure to dry well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694440",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put a thin layer on the affected skin and rub in gently.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694533",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid putting on healthy skin.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10012211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696441",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put on a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696452",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not put on 2 doses or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12501 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14212=[""].join("\n");
var outline_f13_56_14212=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F131672\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16369036\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012208\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012207\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012212\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012213\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012215\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012210\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012211\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012216\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012217\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?24/45/25299?source=related_link\">",
"      Alitretinoin: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_56_14213="Cord edema";
var content_f13_56_14213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F74326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F74326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cord edema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla J Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14213=[""].join("\n");
var outline_f13_56_14213=null;
var title_f13_56_14214="Type II hyperplasia in IPH";
var content_f13_56_14214=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78396&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathology of idiopathic pulmonary hemosiderosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 413px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunoperoxidase staining for cytokeratin number 7 (brown), performed on a transbronchial lung biopsy, demonstrates hyperplasia of type II pneumocytes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Per Praetorius Clausen, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14214=[""].join("\n");
var outline_f13_56_14214=null;
var title_f13_56_14215="HPLC beta chain variants";
var content_f13_56_14215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F50316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F50316&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 604px\">",
"   <div class=\"ttl\">",
"    Beta chain hemoglobin variants on HPLC",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 584px; height: 451px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cation exchange HPLC patterns of beta chain variants. HbA, A2, A",
"    <sub>",
"     1C",
"    </sub>",
"    , A",
"    <sub>",
"     2",
"    </sub>",
"    , F, S, and C are highlighted.",
"    <div class=\"footnotes\">",
"     HPLC: high performance liquid chromatography.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14215=[""].join("\n");
var outline_f13_56_14215=null;
var title_f13_56_14216="Epidemiology, pathogenesis, clinical presentation and diagnosis of viral gastroenteritis in children";
var content_f13_56_14216=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology, pathogenesis, clinical presentation and diagnosis of viral gastroenteritis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14216/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14216/contributors\">",
"     David O Matson, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14216/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14216/contributors\">",
"     Morven S Edwards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14216/contributors\">",
"     George D Ferry, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14216/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14216/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/56/14216/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroenteritis ranks with respiratory tract infection as the most common infectious disease syndrome of humans. Approximately five billion episodes of diarrhea occur worldwide annually, accounting for 15 to 30 percent of all deaths in some countries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bacterial and parasitic gastrointestinal infections have decreased in frequency as a result of improvements in public health infrastructure from the treatment, piping, and proper delivery of drinking water and disposal of sewage. However, viral gastroenteritis has not declined in a comparable fashion from these interventions.",
"   </p>",
"   <p>",
"    The epidemiology, pathogenesis, clinical features, and diagnosis of viral gastroenteritis in children will be reviewed here. Mass immunization with rotavirus vaccines has changed the epidemiology of that infection and of acute infectious gastroenteritis overall. The prevention and treatment of this infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9912?source=see_link\">",
"     \"Prevention and treatment of viral gastroenteritis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGIC AGENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many microbial pathogens cause acute gastroenteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/2\">",
"     2",
"    </a>",
"    ]. In addition, a number of non-infectious conditions can present with symptoms indistinguishable from those of infectious gastroenteritis (",
"    <a class=\"graphic graphic_table graphicRef58814 \" href=\"UTD.htm?24/0/24589\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13529?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of diarrhea in children\", section on 'Causes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Microbes generally are called \"enteritis pathogens\" when their infection results in intestinal symptoms. Enteritis pathogens newly recognized since 1970 include viruses (",
"    <a class=\"graphic graphic_table graphicRef61330 \" href=\"UTD.htm?7/50/7980\">",
"     table 2",
"    </a>",
"    ), parasitic agents (eg,",
"    <em>",
"     Isospora belli",
"    </em>",
"    ,",
"    <em>",
"     Cryptosporidium",
"    </em>",
"    ,",
"    <em>",
"     Giardia",
"    </em>",
"    ), and bacterial agents (eg,",
"    <em>",
"     Campylobacter jejuni",
"    </em>",
"    ,",
"    <em>",
"     Campylobacter upsaliensis",
"    </em>",
"    ,",
"    <em>",
"     Clostridium difficile",
"    </em>",
"    , some",
"    <em>",
"     Escherichia coli",
"    </em>",
"    ,",
"    <em>",
"     Salmonella",
"    </em>",
"    strains, Mycobacteria such as",
"    <em>",
"     Mycobacterium avium",
"    </em>",
"    complex). The illness caused by enteritis pathogens varies but generally includes a combination of diarrhea, vomiting, and fever, of differing duration and severity.",
"   </p>",
"   <p>",
"    The viral gastroenteritis pathogens all infect the intestine and induce gastrointestinal symptoms. This shared ability contrasts with so-called \"enteric viruses\" that may infect the intestine but predominantly produce manifestations at extraintestinal sites. For example, many picornaviruses (echoviruses, coxsackieviruses, and polioviruses) and the SARS coronavirus cause mild gastroenteritis, but the illnesses for which they are recognized are extraintestinal (eg, pleuritis, myocarditis, and neuritis or pneumonia).",
"   </p>",
"   <p>",
"    The proven pathogens of viral gastroenteritis are (",
"    <a class=\"graphic graphic_table graphicRef61330 \" href=\"UTD.htm?7/50/7980\">",
"     table 2",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rotaviruses",
"     </li>",
"     <li>",
"      Caliciviruses",
"     </li>",
"     <li>",
"      Astroviruses",
"     </li>",
"     <li>",
"      Enteric adenovirus serotypes 40 and 41 (group F)",
"     </li>",
"     <li>",
"      Some picornaviruses (eg, Aichi virus)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Natural rotavirus transmission has been markedly curtailed in North America since mass immunization began again in 2006. Commercial assays are available for rotaviruses, astroviruses, adenoviruses 40 and 41, and",
"    <em>",
"     Norovirus",
"    </em>",
"    caliciviruses.",
"   </p>",
"   <p>",
"    Additional viruses, including non-group F adenoviruses, coronaviruses, pestiviruses, Breda virus, parvoviruses, toroviruses, and picobirnaviruses and other picornaviruses (eg, echovirus 22) have been linked to human gastroenteritis with varying degrees of certainty [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Most of these viruses cause gastroenteritis in animals, a factor that directed interest to their role in human illness. Animal-to-human transmission certainly has occurred for many of these agents, although the likelihood and frequency of cross-species infections are unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral gastroenteritis occurs in both developed and developing countries. The epidemiology presented here generally pertains to developed countries.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Burden of illness &ndash; Approximately 1 in 50 children born each year in developed nations is hospitalized for acute gastroenteritis sometime during childhood (&lt;18 years of age). Viral gastroenteritis accounts for approximately 3 to 5 percent of all hospital days and 7 to 10 percent of hospitalizations each year for children younger than 18 years [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/1,6\">",
"       1,6",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      More than 95 percent of viral gastroenteritis hospitalizations occur in children younger than 5 years. The highest rate of illness occurs in children between 3 and 24 months of age, increased risk resulting from clearance of transplacental antibody and weaning, and decreased risk with acquisition of protective immunity [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/7,8\">",
"       7,8",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Among children younger than 5 years, the average rate of illness ranges from one to five episodes per child-year, resulting in a total of 15 to 25 million episodes of acute gastroenteritis per year in the US [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/6,9,10\">",
"       6,9,10",
"      </a>",
"      ]. Approximately 3 to 5 million of these episodes result in clinician visits, and 200,000 in hospitalization.",
"     </li>",
"     <li>",
"      Etiology &ndash; Before rotavirus immunization, approximately one-half of hospitalizations for acute, nonbacterial gastroenteritis in children in the United States were caused by rotavirus, and 5 to 15 percent each by caliciviruses, astroviruses, and enteric adenoviruses. The remaining one-fourth to one-third of cases cannot be linked to any of these pathogens, but probably represent underdiagnosis of the common pathogens [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/11-13\">",
"       11-13",
"      </a>",
"      ]. Rotavirus also accounts for the majority of cases of severe viral gastroenteritis in developing countries [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/14-16\">",
"       14-16",
"      </a>",
"      ]. Rotavirus immunization is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=see_link\">",
"       \"Rotavirus vaccines\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Season &ndash; Hospitalizations for viral gastroenteritis peak in the winter; 70 to 90 percent of viral gastroenteritis-related hospitalizations occur during the winter. During the peak month, which varies from region to region, viral gastroenteritis may account for 20 to 25 percent of pediatric hospitalizations.",
"     </li>",
"     <li>",
"      Transmission &ndash; The fecal-oral route is the major mechanism of transmission of the viral enteropathogens. However, the possibility of respiratory tract inoculation has been suggested by the explosiveness of some outbreaks of rotavirus and calicivirus infection in situations apparently precluding fecal-oral spread [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/17,18\">",
"       17,18",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predominant clinical manifestations of rotaviral gastroenteritis result from intestinal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. The first day after exposure, the virus infects enterocytes within the villous epithelium of the jejunum and ileum, leading to destruction of the cells of this layer. Destruction of enterocytes results in a transudation of fluid into the intestinal lumen and net loss of fluid and salt in feces. During days two to five after infection, adjacent villi fuse, reducing the surface area of injury and improving integrity of the barrier against fluid loss. From days 6 to 10 after infection, normal villous architecture is restored.",
"   </p>",
"   <p>",
"    Intestinal injuries lead to a loss of the ability to digest food (especially complex sugars) and to absorb digested food across the intestinal mucosa. This inability to digest complex sugars manifests as transient lactose intolerance.",
"   </p>",
"   <p>",
"    In addition, rotaviruses may cause secretory diarrhea via the nonstructural glycoprotein (NSP4) enterotoxin, which alters intracellular Ca+2 mobilization in GI epithelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Elevation of ionized Ca+2 leads to age-dependent halide ion movement across the plasma membrane. Altered Ca+2 mobilization may signal other Ca+2-sensitive cellular processes, such as cation channels and ion and solute transporters to increase fluid secretion while curtailing fluid absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/25\">",
"     25",
"    </a>",
"    ]. These primary Ca+2-dependent steps appear to be cyclic nucleotide-independent. A secondary component appears to involve the enteric nervous system and may be cyclic nucleotide-dependent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of viral gastroenteritis include diarrhea, vomiting, fever, anorexia, headache, abdominal cramps, and myalgia. None of these symptoms clearly distinguishes among the viral pathogens or viral gastroenteritis from diarrheal illness due to bacterial or parasitic organisms. However, there are some clinical and epidemiologic clues that favor viral over other causes of gastroenteritis. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Viral gastroenteritis generally manifests with loose, watery stools that can be normal in color or relatively pale colored. As many as 20 episodes of vomiting and 20 episodes of diarrhea can occur during a single day. Stools may be odorless or foul-smelling.",
"   </p>",
"   <p>",
"    The constellation of symptoms varies from day to day and from person to person. Illness usually begins 12 hours to 4 days after exposure and generally lasts for three to seven days [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/19,21,22\">",
"     19,21,22",
"    </a>",
"    ]. Children may have only diarrhea or vomiting at first, but with progression become sufficiently ill to require hospitalization. Other symptoms may develop as the disease evolves; approximately 10 percent of children hospitalized for rotavirus infection have only fever",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vomiting at the time of admission [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although viral gastroenteritis is common, and virtually every child has more than one symptomatic episode, most viral enteric infections are asymptomatic, but the asymptomatic patient may transmit the virus to others [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/7,27\">",
"     7,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors associated with severe or prolonged clinical manifestations include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      First infection with a particular pathogen",
"     </li>",
"     <li>",
"      Malnutrition or an immunocompromised host",
"     </li>",
"     <li>",
"      Lack of maternally acquired immunity (eg, antibody acquired transplacentally or in human milk)",
"     </li>",
"     <li>",
"      Community change in serotype of the infecting strain",
"     </li>",
"     <li>",
"      Large inoculum size",
"     </li>",
"     <li>",
"      Strain virulence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Except for Aichi virus, each of the enteric viruses causing gastroenteritis includes multiple serotypes. No differences in clinical outcome have been attributed specifically to serotype or to differences in age at time of infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial evaluation of children with symptoms of acute gastroenteritis focuses on assessment of severity of illness and exclusion of causes of vomiting",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diarrhea that require definitive therapy (eg, meningitis, acute abdominal processes, diabetes mellitus, and toxic ingestions). A complete blood count (for evidence of anemia or hemolysis; elevated white blood cell or band count that may indicate bacterial infection), serum electrolytes, and stool studies (eg, fecal leukocytes, pH, reducing substances) may be helpful.",
"   </p>",
"   <p>",
"    The disease severity is reflected by the degree of hypovolemia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/2\">",
"     2",
"    </a>",
"    ]. Weight loss, prolonged capillary refill time, loss of skin turgor, and abnormal respiratory pattern are the best individual signs of hypovolemia. Other important signs include elevated temperature and pulse, diminished systolic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    diastolic blood pressure, sunken fontanel (in children whose fontanel remains open), and dry mucus membranes (",
"    <a class=\"graphic graphic_table graphicRef76198 \" href=\"UTD.htm?13/5/13404\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3607?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical assessment and diagnosis of hypovolemia (dehydration) in children\", section on 'Clinical assessment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Laboratory studies to evaluate the severity of hypovolemia are discussed separately. Measurement of serum electrolytes is generally indicated for children who require intravenous fluid repletion, for these values will guide rehydration approaches. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3607?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical assessment and diagnosis of hypovolemia (dehydration) in children\", section on 'Laboratory testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation may provide clues to suggest a particular gastroenteritis pathogen.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Viral versus other pathogens",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The age of the child, associated findings, appearance of the stool, and history of exposures may provide clues to distinguish viral from other pathogens.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Age &ndash; Bacterial and parasitic agents generally cause gastroenteritis in children at an older age (eg, 2 to 4 years), whereas viral pathogens tend to cause serious gastroenteritis in those younger than 2 years.",
"     </li>",
"     <li>",
"      Presence of blood or mucus &ndash; The presence of gross blood or mucus in the stool suggests bacterial or parasitic infection; these almost never occur with viral gastroenteritis. Blood detected in the stool only by guaiac test is not a useful discriminator.",
"     </li>",
"     <li>",
"      Exposures &ndash; Bacterial or parasitic acute gastroenteritis may be associated with foreign travel, exposure to poultry or other farm animals, or consumption of processed meat.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Stool studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several stool studies also may provide clues that distinguish viral from other pathogens:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fecal leukocytes &ndash; Presence of fecal leukocytes suggests a bacterial or parasitic etiology (",
"      <a class=\"graphic graphic_table graphicRef73254 \" href=\"UTD.htm?3/19/3388\">",
"       table 4",
"      </a>",
"      ). Fecal leukocytes are appreciated by examining a fecal smear stained with a Wright stain. Fecal leukocytes indicate inflammation in the bowel wall but do not distinguish between infectious and non-infectious inflammatory processes. If the cause is infectious, viral agents are unlikely. Most bacteria cause a polymorphonuclear inflammation, although",
"      <em>",
"       Salmonella typhi",
"      </em>",
"      and",
"      <em>",
"       Entamoeba histolytica",
"      </em>",
"      frequently cause a mononuclear reaction.",
"     </li>",
"     <li>",
"      Stool pH and reducing substances &ndash; Stool pH &lt;6 and the presence of reducing substances are indicative of hydrocarbon intolerance (which is frequently present in viral gastroenteritis)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Viral pathogens",
"    </span>",
"    &nbsp;&mdash;&nbsp;Attempts to distinguish among the viral causes of a gastroenteritis episode by history generally are discouraging. However, clinical features and the pattern of illness may help to implicate a particular virus (",
"    <a class=\"graphic graphic_table graphicRef80471 \" href=\"UTD.htm?32/63/33787\">",
"     table 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Rotaviruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rotaviruses are the most important cause of viral gastroenteritis because rotaviruses are detected more frequently as the severity of illness increases. Before rotavirus immunization, rotaviruses accounted for approximately 10 percent of diarrhea episodes that required medical treatment, and 50 percent of those that required hospitalization. At the peak of the winter gastroenteritis season, a child with dehydration requiring medical intervention had a 70 to 90 percent chance of having rotavirus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/6\">",
"     6",
"    </a>",
"    ]. The effects of rotavirus immunization on these statistics continue to be evaluated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=see_link\">",
"     \"Rotavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical characteristics of children hospitalized with acute gastroenteritis in whom rotavirus was and was not detected were described in two studies (",
"    <a class=\"graphic graphic_table graphicRef66899 \" href=\"UTD.htm?6/1/6174\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first study, in which diarrhea was a criterion for enrollment, vomiting and isotonic dehydration were more frequent among children with rotavirus infection.",
"     </li>",
"     <li>",
"      In the second study, which enrolled patients with diarrhea or vomiting not associated with a respiratory or structural cause (eg, pyloric stenosis), diarrhea was the most common presenting symptom and was more common among children hospitalized with rotavirus gastroenteritis than with other etiologies (",
"      <a class=\"graphic graphic_table graphicRef66899 \" href=\"UTD.htm?6/1/6174\">",
"       table 6",
"      </a>",
"      ). Children with rotavirus infection also were more likely to have vomiting and high fever (&gt;39&ordm;C) than those with acute gastroenteritis of other causes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During the first five years of life, the frequency of rotavirus detection varies according to age and symptoms at the time of admission (",
"    <a class=\"graphic graphic_table graphicRef79222 \" href=\"UTD.htm?39/3/39997\">",
"     table 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/12\">",
"     12",
"    </a>",
"    ]. Rotavirus is detected in one-quarter to one-third of preschool-age children who require hospitalization for diarrhea, vomiting,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fever (in any combination). The clinical spectrum narrows with increasing age, as illustrated below:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      At 0 to 2 months of age, rotavirus is detected in 5 to 20 percent of patients who present with diarrhea, vomiting, or fever, alone or in combination",
"     </li>",
"     <li>",
"      After 5 months, rotavirus detection is unlikely in the absence of diarrhea and vomiting",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Other viruses",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of the viral gastroenteritis episodes requiring hospitalization that are not associated with rotavirus are caused by astrovirus or calicivirus, which also occur predominantly in the winter months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/28-30\">",
"     28-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vomiting tends to be more prominent, and more likely to be the sole presenting symptom, in caliciviral gastroenteritis than in other types of viral gastroenteritis. Astrovirus, calicivirus, and adenovirus gastroenteritis is consistently milder than rotavirus gastroenteritis.",
"   </p>",
"   <p>",
"    Astrovirus and calicivirus episodes usually are of shorter duration than rotavirus gastroenteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/29,31-33\">",
"     29,31-33",
"    </a>",
"    ]. In contrast, children admitted to the hospital with enteric adenovirus infection are more likely than those with rotavirus infection to have diarrhea that persists for more than five days [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/34-36\">",
"     34-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Outbreaks that include a large (&gt;30 percent) proportion of cases in patients older than 2 years probably are caused by caliciviruses and astroviruses. A teenager or adult with severe acute gastroenteritis is more likely to have calicivirus infection, especially as part of a common-source outbreak, particularly if the outbreak is linked to water or food contamination [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/37-41\">",
"     37-41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of acute viral gastroenteritis is made clinically. Clinical features suggestive of viral gastroenteritis include: age younger than 2 years; watery diarrhea; absence of gross blood, mucus, and fecal leukocytes; stool pH &lt;6; and the presence of reducing substances. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Clinical presentation'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H7\">",
"     'Differential diagnosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Etiologic diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral gastroenteritis pathogens are excreted in the stool and can be detected one to two days before symptoms begin through several days after symptoms have resolved [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/42\">",
"     42",
"    </a>",
"    ]. Testing for specific viruses usually is not necessary in immunocompetent hosts with routine gastroenteritis. However, it may be indicated during outbreaks of gastroenteritis, to make decisions about specific therapy, and for cohorting and isolation of hospitalized patients.",
"   </p>",
"   <p>",
"    Submission of a sample (or samples) for viral testing should occur when outbreaks of gastroenteritis occur in a healthcare institution, when specific antiviral measures (eg, immunoglobulin or colostrum) are considered, and when identification of a particular virus is needed to assess success of control measures, such as cohorting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9912?source=see_link\">",
"     \"Prevention and treatment of viral gastroenteritis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Stool cultures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    stool examination for ova and parasites may be indicated in cases of persistent diarrhea, in immunocompromised hosts, when infectious etiology must be excluded to verify another diagnosis (eg, inflammatory bowel disease), in the setting of an outbreak, and when immunosuppressive therapy may be initiated (eg, inflammatory disease, transplantation) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14216/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Specific viral assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral gastroenteritis pathogens can be detected by specific assays for single agents or broadly reactive assays. Commercial assays are available for rotaviruses, astroviruses, adenoviruses 40 and 41, and",
"    <em>",
"     Norovirus",
"    </em>",
"    caliciviruses. The widely available assays for detection of single agents are enzyme immunoassays (EIAs), latex agglutination (LA), and reverse transcription-polymerase chain reaction (RT-PCR).",
"   </p>",
"   <p>",
"    The RT-PCR genomic detection method is needed for astrovirus and calicivirus detection because antigen detection methods (EIA and LA) are not yet mature for these viruses, and RT-PCR is more sensitive than EIA or LA in most situations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/14/43241?source=see_link&amp;anchor=H24#H24\">",
"     \"Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Aichi virus is little studied; in general, picornaviruses are detected by inoculation in cell culture.",
"   </p>",
"   <p>",
"    Electron microscopy (EM) is the only method that can simultaneously identify the presence and type of several viral enteropathogens, although the method is fairly insensitive. EM is the first method used at some centers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Sample collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;For all of the assays described above, fresh, bulk unfrozen stool (a soiled diaper may be used) should be sent to the laboratory. The assays can be performed with less than 0.1 g of stool, although a greater quantity improves sensitivity (from approximately 70 to &gt;90 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=see_link\">",
"       \"Patient information: Viral gastroenteritis (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=see_link\">",
"       \"Patient information: Diarrhea in children (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/13/27858?source=see_link\">",
"       \"Patient information: Rotavirus infection (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"       \"Patient information: Acute diarrhea in children (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Proven pathogens of viral gastroenteritis include rotaviruses, caliciviruses, astroviruses, enteric adenovirus serotypes 40 and 41, and some picornaviruses (",
"      <a class=\"graphic graphic_table graphicRef61330 \" href=\"UTD.htm?7/50/7980\">",
"       table 2",
"      </a>",
"      ). Rotaviruses are the most important cause in regions that do not immunize against rotavirus. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiologic agents'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations of viral gastroenteritis include diarrhea, vomiting, fever, anorexia, headache, abdominal cramps, and myalgia. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial evaluation focuses on assessing severity of illness and excluding causes of vomiting and diarrhea that require definitive therapy (eg, meningitis, acute abdominal processes, diabetes mellitus, and toxic ingestions). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory tests in the initial evaluation may include a complete blood count (for evidence of anemia or hemolysis), serum electrolytes, and stool studies (eg, fecal leukocytes, pH, reducing substances). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Initial evaluation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3607?source=see_link&amp;anchor=H6#H6\">",
"       \"Clinical assessment and diagnosis of hypovolemia (dehydration) in children\", section on 'Laboratory testing'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H7\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical features may suggest a particular pathogen. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Viral gastroenteritis is suggested by watery stools without blood or mucus, the absence of fecal leukocytes, stool pH &lt;6, and the presence of reducing substances. The pattern of illness may help to implicate a particular virus (",
"      <a class=\"graphic graphic_table graphicRef80471 \" href=\"UTD.htm?32/63/33787\">",
"       table 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Bacterial or parasitic gastroenteritis is suggested by fecal leukocytes, gross blood, or mucus in the stool. Bacterial or parasitic gastroenteritis tends to occur in children 2 to 4 years of age and may be associated with foreign travel, exposure to poultry or other farm animals, and consumption of processed meat.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of acute viral gastroenteritis is made clinically. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical indications for specific viral assays may include outbreaks of gastroenteritis in a closed population, such as a hospital or nursing home; consideration of treatment with specific antiviral measures (eg, immunoglobulin or colostrum); and to evaluate the success of various infection control measures (eg, cohorting). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Etiologic diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The treatment of viral gastroenteritis in children is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9912?source=see_link\">",
"       \"Prevention and treatment of viral gastroenteritis in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/1\">",
"      Glass RI, Bresee J, Jiang B, et al. Gastroenteritis viruses: an overview. Novartis Found Symp 2001; 238:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/2\">",
"      Guarino A, Albano F, Ashkenazi S, et al. European Society for Paediatric Gastroenterology, Hepatology, and Nutrition/European Society for Paediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe. J Pediatr Gastroenterol Nutr 2008; 46 Suppl 2:S81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/3\">",
"      Jamieson FB, Wang EE, Bain C, et al. Human torovirus: a new nosocomial gastrointestinal pathogen. J Infect Dis 1998; 178:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/4\">",
"      Yamashita T, Sakae K, Tsuzuki H, et al. Complete nucleotide sequence and genetic organization of Aichi virus, a distinct member of the Picornaviridae associated with acute gastroenteritis in humans. J Virol 1998; 72:8408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/5\">",
"      Joki-Korpela P, Hyypi&auml; T. Diagnosis and epidemiology of echovirus 22 infections. Clin Infect Dis 1998; 27:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/6\">",
"      Matson DO, Estes MK. Impact of rotavirus infection at a large pediatric hospital. J Infect Dis 1990; 162:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/7\">",
"      Vel&aacute;zquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996; 335:1022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/8\">",
"      Newburg DS, Peterson JA, Ruiz-Palacios GM, et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998; 351:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/9\">",
"      Tucker AW, Haddix AC, Bresee JS, et al. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998; 279:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/10\">",
"      Ho MS, Glass RI, Pinsky PF, et al. Diarrheal deaths in American children. Are they preventable? JAMA 1988; 260:3281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/11\">",
"      Rodriguez WJ, Kim HW, Arrobio JO, et al. Clinical features of acute gastroenteritis associated with human reovirus-like agent in infants and young children. J Pediatr 1977; 91:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/12\">",
"      Staat MA, Azimi PH, Berke T, et al. Clinical presentations of rotavirus infection among hospitalized children. Pediatr Infect Dis J 2002; 21:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/13\">",
"      Oh DY, Gaedicke G, Schreier E. Viral agents of acute gastroenteritis in German children: prevalence and molecular diversity. J Med Virol 2003; 71:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/14\">",
"      Doan LT, Okitsu S, Nishio O, et al. Epidemiological features of rotavirus infection among hospitalized children with gastroenteristis in Ho Chi Minh City, Vietnam. J Med Virol 2003; 69:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/15\">",
"      Subekti D, Lesmana M, Tjaniadi P, et al. Incidence of Norwalk-like viruses, rotavirus and adenovirus infection in patients with acute gastroenteritis in Jakarta, Indonesia. FEMS Immunol Med Microbiol 2002; 33:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/16\">",
"      Steele AD, Nimzing L, Peenze I, et al. Circulation of the novel G9 and G8 rotavirus strains in Nigeria in 1998/1999. J Med Virol 2002; 67:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/17\">",
"      Sawyer LA, Murphy JJ, Kaplan JE, et al. 25- to 30-nm virus particle associated with a hospital outbreak of acute gastroenteritis with evidence for airborne transmission. Am J Epidemiol 1988; 127:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/18\">",
"      Foster SO, Palmer EL, Gary GW Jr, et al. Gastroenteritis due to rotavirus in an isolated Pacific island group: an epidemic of 3,439 cases. J Infect Dis 1980; 141:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/19\">",
"      Schreiber DS, Blacklow NR, Trier JS. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med 1973; 288:1318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/20\">",
"      Agus SG, Dolin R, Wyatt RG, et al. Acute infectious nonbacterial gastroenteritis: intestinal histopathology. Histologic and enzymatic alterations during illness produced by the Norwalk agent in man. Ann Intern Med 1973; 79:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/21\">",
"      Shepherd RW, Gall DG, Butler DG, Hamilton JR. Determinants of diarrhea in viral enteritis. The role of ion transport and epithelial changes in the ileum in transmissible gastroenteritis in piglets. Gastroenterology 1979; 76:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/22\">",
"      Mebus CA, Wyatt RG, Kapikian AZ. Intestinal lesions induced in gnotobiotic calves by the virus of human infantile gastroenteritis. Vet Pathol 1977; 14:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/23\">",
"      Ball JM, Tian P, Zeng CQ, et al. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 1996; 272:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/24\">",
"      Huang H, Schroeder F, Zeng C, et al. Membrane interactions of a novel viral enterotoxin: rotavirus nonstructural glycoprotein NSP4. Biochemistry 2001; 40:4169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/25\">",
"      Morris AP, Estes MK. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VIII. Pathological consequences of rotavirus infection and its enterotoxin. Am J Physiol Gastrointest Liver Physiol 2001; 281:G303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/26\">",
"      Lundgren O, Peregrin AT, Persson K, et al. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 2000; 287:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/27\">",
"      Guerrero ML, Noel JS, Mitchell DK, et al. A prospective study of astrovirus diarrhea of infancy in Mexico City. Pediatr Infect Dis J 1998; 17:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/28\">",
"      Bates PR, Bailey AS, Wood DJ, et al. Comparative epidemiology of rotavirus, subgenus F (types 40 and 41) adenovirus and astrovirus gastroenteritis in children. J Med Virol 1993; 39:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/29\">",
"      Nazer H, Rice S, Walker-Smith JA. Clinical associations of stool astrovirus in childhood. J Pediatr Gastroenterol Nutr 1982; 1:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/30\">",
"      Utagawa ET, Nishizawa S, Sekine S, et al. Astrovirus as a cause of gastroenteritis in Japan. J Clin Microbiol 1994; 32:1841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/31\">",
"      Cruz JR, Bartlett AV, Herrmann JE, et al. Astrovirus-associated diarrhea among Guatemalan ambulatory rural children. J Clin Microbiol 1992; 30:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/32\">",
"      Esahli H, Breb&auml;ck K, Bennet R, et al. Astroviruses as a cause of nosocomial outbreaks of infant diarrhea. Pediatr Infect Dis J 1991; 10:511.",
"     </a>",
"    </li>",
"    <li>",
"     Parada, E, Walter, J, Jakab, F, et al. Comparison of clinical features of enteric virus infections among hospitalized children in the USA. Oral presentation. XXIIth International Congress of Virology, Paris, France, July 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/34\">",
"      Grimwood K, Carzino R, Barnes GL, Bishop RF. Patients with enteric adenovirus gastroenteritis admitted to an Australian pediatric teaching hospital from 1981 to 1992. J Clin Microbiol 1995; 33:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/35\">",
"      Uhnoo I, Olding-Stenkvist E, Kreuger A. Clinical features of acute gastroenteritis associated with rotavirus, enteric adenoviruses, and bacteria. Arch Dis Child 1986; 61:732.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/36\">",
"      Kotloff KL, Losonsky GA, Morris JG Jr, et al. Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings. Pediatrics 1989; 84:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/37\">",
"      Kaplan JE, Feldman R, Campbell DS, et al. The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health 1982; 72:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/38\">",
"      Lew JF, LeBaron CW, Glass RI, et al. Recommendations for collection of laboratory specimens associated with outbreaks of gastroenteritis. MMWR Recomm Rep 1990; 39:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/39\">",
"      Adler JL, Zickl R. Winter vomiting disease. J Infect Dis 1969; 119:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/40\">",
"      Hale A, Mattick K, Lewis D, et al. Distinct epidemiological patterns of Norwalk-like virus infection. J Med Virol 2000; 62:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/41\">",
"      Green KY, Belliot G, Taylor JL, et al. A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis 2002; 185:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14216/abstract/42\">",
"      Pickering LK, Bartlett AV 3rd, Reves RR, Morrow A. Asymptomatic excretion of rotavirus before and after rotavirus diarrhea in children in day care centers. J Pediatr 1988; 112:361.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5984 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-08BE826B45-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14216=[""].join("\n");
var outline_f13_56_14216=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H20\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGIC AGENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Viral versus other pathogens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Stool studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Viral pathogens",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Rotaviruses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Other viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Etiologic diagnosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Specific viral assays",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Sample collection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5984\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5984|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/0/24589\" title=\"table 1\">",
"      Etiology of diarrhea",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/50/7980\" title=\"table 2\">",
"      Viral gastroenteritis pathogens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/5/13404\" title=\"table 3\">",
"      Pediatric signs of dehydration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/19/3388\" title=\"table 4\">",
"      Fecal leukocyte testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/63/33787\" title=\"table 5\">",
"      Viral gastroenteritis epi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/1/6174\" title=\"table 6\">",
"      Viral gastroenteritis signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?39/3/39997\" title=\"table 7\">",
"      Viral gastroenteritis sxs",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/33/3607?source=related_link\">",
"      Clinical assessment and diagnosis of hypovolemia (dehydration) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/14/43241?source=related_link\">",
"      Epidemiology, clinical manifestations and diagnosis of norovirus and related viruses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13529?source=related_link\">",
"      Evaluation of diarrhea in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=related_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?33/34/34338?source=related_link\">",
"      Patient information: Diarrhea in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/13/27858?source=related_link\">",
"      Patient information: Rotavirus infection (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/3/9267?source=related_link\">",
"      Patient information: Viral gastroenteritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/43/9912?source=related_link\">",
"      Prevention and treatment of viral gastroenteritis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/62/40937?source=related_link\">",
"      Rotavirus vaccines",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_56_14217="Venous Doppler for fetal assessment";
var content_f13_56_14217=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Venous Doppler for fetal assessment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14217/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14217/contributors\">",
"     Ahmet Alexander Baschat, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14217/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14217/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14217/contributors\">",
"     Deborah Levine, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14217/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14217/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/56/14217/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 14, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial Doppler waveforms are related to both input pressure and downstream vascular resistance. Fetal arterial Doppler assessment has predominantly utilized the umbilical artery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/1\">",
"     1",
"    </a>",
"    ], fetal aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/2\">",
"     2",
"    </a>",
"    ] and middle cerebral artery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/3\">",
"     3",
"    </a>",
"    ]. Doppler assessment of these, and other, fetal arteries provides information on regional blood flow and perfusion of individual organs, as well as giving insights into the fetal circulatory state in health and disease. However, evaluation of cardiovascular status by arterial Doppler alone is inadequate in fetal disorders with impaired cardiac function since cardiac function is not accounted for in arterial waveform analysis. Extending Doppler ultrasound assessment to the fetal venous circulation overcomes this limitation.",
"   </p>",
"   <p>",
"    Examination of venous Doppler waveforms was first reported in the early 1980s [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. Clinical utilization of this technique began in the 1990s and has since emerged as the primary means of assessing forward function of the fetal heart in many fetal disease states.",
"   </p>",
"   <p>",
"    Venous Doppler for fetal assessment will be reviewed here. The principles of Doppler ultrasound and the use of Doppler sonography to examine the umbilical artery are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/30/10728?source=see_link\">",
"     \"Doppler ultrasound of the umbilical artery for fetal surveillance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     FETAL CIRCULATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The placenta is the primary organ for nutrient and respiratory exchange between the maternal and fetal compartments. Since the lungs and gastrointestinal system have no role in this process, the fetal circulation has several unique features that allow differential distribution of oxygen and nutrient rich blood to vital organs and recirculation of oxygen and nutrient poor blood back to the placenta. Differential distribution and recirculation are achieved at the level of the ductus venosus, the foramen ovale, the aortic isthmus, and the origin of the umbilical arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/7\">",
"     7",
"    </a>",
"    ]. A detailed description of the fetal circulation across gestation can be found elsewhere [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Venous anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oxygen and nutrient rich blood from the placenta enters the fetal circulation through the umbilical vein. The intraabdominal portion of the umbilical vein ascends steeply in the falciform ligament and then enters the fetal liver where it turns right and joins the transverse portion of the left portal vein (",
"    <a class=\"graphic graphic_figure graphicRef66765 \" href=\"UTD.htm?14/43/15032\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The ductus venosus originates from the umbilical vein just before its turn to the right and courses steeply upward to join the IVC in a funnel-like venous confluence just below the level of the right atrium. This subdiaphragmatic venous vestibulum is formed by the confluence of the three hepatic veins, the ductus venous, and the IVC [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/9\">",
"     9",
"    </a>",
"    ]. The right atrium receives venous return from the upper part of the body through the superior vena cava (SVC) and from the myocardium via the coronary sinus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Differential blood flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since the tributaries to the right atrium carry blood with different concentrations of nutrients and oxygen, appropriate channeling is necessary to ensure sufficient",
"    <span class=\"nowrap\">",
"     nutrient/oxygen",
"    </span>",
"    delivery to the heart, brain, and body. This is achieved through differential velocities of the incoming venous blood streams and differential directionality of blood entering the right atrium.",
"   </p>",
"   <p>",
"    The ductus venosus develops at approximately 7 weeks of gestation and shows relatively little increase in size subsequently, in contrast to the other precordial veins which grow proportionally with the embryo [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/10\">",
"     10",
"    </a>",
"    ]. The diameter of the ductus measures approximately one-third of the umbilical vein diameter from midgestation onwards. As a consequence, blood from the umbilical vein undergoes significant acceleration upon entering the ductus venosus [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/11\">",
"     11",
"    </a>",
"    ]. This accelerated blood stream enters the IVC together with left hepatic venous return and the combined flow is directed through the foramen ovale into the left atrium.",
"   </p>",
"   <p>",
"    By comparison, the venous return from the right and middle hepatic veins and IVC have slower blood flow velocities and are directed towards the right atrium. There is relatively little mixing of the venous returns from the ductus",
"    <span class=\"nowrap\">",
"     venosus/left",
"    </span>",
"    hepatic vein and the right-middle hepatic",
"    <span class=\"nowrap\">",
"     veins/IVC",
"    </span>",
"    because of the differences in velocity and direction of the incoming blood streams.",
"   </p>",
"   <p>",
"    As a result, oxygen rich blood reaches the left ventricle through the foramen ovale while oxygen-poor blood enters the right ventricle through the tricuspid valve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Distribution of cardiac output",
"    </span>",
"    &nbsp;&mdash;&nbsp;Left ventricular output is distributed to the myocardium via the coronary vessels and to the brain and upper body via the brachiocephalic vessels, which arise from the aortic arch before it is joined by the ductus arteriosus. Right ventricular output largely bypasses the lungs and reaches the aorta through the ductus arteriosus. The admixture of blood originating from the individual ventricles eventually reaches the placenta via the umbilical arteries (",
"    <a class=\"graphic graphic_figure graphicRef70458 \" href=\"UTD.htm?10/39/10864\">",
"     figure 2",
"    </a>",
"    ). The fraction of cardiac output directed to the placenta in normally grown fetuses averages 32 percent from 18 to 32 weeks, and 21 percent beyond 32 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/12\">",
"     12",
"    </a>",
"    ]",
"   </p>",
"   <p>",
"    It is apparent that the fetal venous circulation is of major importance as it is the driving force directing the appropriate delivery of ventricular output. The ductus venosus has two central regulatory roles in this process:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      To control the relative proportions of",
"      <span class=\"nowrap\">",
"       oxygen/nutrient",
"      </span>",
"      rich umbilical venous blood that are distributed to the liver and heart.",
"     </li>",
"     <li>",
"      To maintain intra-atrial separation of blood streams by significantly accelerating the velocity of blood from the umbilical vein.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Under physiologic conditions, 60 to 70 percent of umbilical venous blood in the human fetus is distributed to the liver and the remainder to the heart. With chronic hypoxemia, this proportion may be modulated so that a larger proportion of umbilical venous blood can bypass the liver to reach the heart (see below) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Atrial pressure changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Umbilical vein blood flow is constant towards the fetus. With this notable exception, all venous vessels have a complex waveform pattern that is related to the pressure changes in the atria throughout the cardiac cycle. The events of the cardiac cycle that are of importance in this context are: ventricular systole, the early phase of ventricular diastole (before atrial systole has occurred), and atrial systole:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Ventricular systole",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrical impulses from the sino-atrial node initiate coordinated atrial and ventricular contractions as they reach the ventricular muscle mass. Ventricular systole shortens the myocardial muscle mass, which makes the closed atrioventricular (AV) valves descend and results in a pressure drop in both atria.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Early ventricular diastole",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the beginning of ventricular diastole, the myocardium relaxes, the AV valves move back up toward their resting position, and intraatrial pressures increase.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Atrial systole",
"    </span>",
"    &nbsp;&mdash;&nbsp;The discharge of the sinoatrial node at the end of diastole initiates an atrial contraction that produces a rapid rise in intraatrial pressure. When atrial pressure exceeds intraventricular pressure, the AV valves open leading to a rapid pressure drop in the atria.",
"   </p>",
"   <p>",
"    Forward flow in the venous system is determined by the pressure difference to the right atrium. Forward flow is greatest during ventricular systole, with the next greatest flow during early ventricular diastole. This results in a larger systolic and a smaller diastolic peak in the venous flow velocity profile (S- and D- waves respectively).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Venous flow velocity waveforms",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pressure difference between atria and veins are smaller at the end of ventricular systole, and particularly during atrial systole, producing two troughs (the y-descent and a-wave, respectively). Although the venous flow velocity waveform actually has four phases (S-wave, D-wave, v-descent, and a-wave), it is typically described as triphasic: S-, D-, and a- waves (",
"    <a class=\"graphic graphic_figure graphicRef57144 \" href=\"UTD.htm?15/22/15726\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The relative and absolute magnitudes of these waves varies for the individual venous vessels and determines their typical waveform patterns. The ductus venosus has the highest forward velocities in the venous system, therefore blood flow is antegrade throughout the cardiac cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/14\">",
"     14",
"    </a>",
"    ]. By comparison, the hepatic veins have lower antegrade velocities so the pressure difference to the right atrium may result in a temporary reversal of blood flow during atrial systole [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/15\">",
"     15",
"    </a>",
"    ]. The same can be observed in the IVC and SVC, which have the most direct connection to the right atrium [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. With increasing distance from the heart the typical flow velocity profile is maintained (eg, in the jugular veins) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/18\">",
"     18",
"    </a>",
"    ], but may become increasingly attenuated (eg, in the cerebral transverse sinus) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler investigation of different venous systems at defined anatomic sites requires modification of technique depending upon the vessel being examined (",
"    <a class=\"graphic graphic_waveform graphicRef70260 \" href=\"UTD.htm?14/30/14823\">",
"     waveform 1",
"    </a>",
"    ). In addition, it is of critical importance to perform venous Doppler studies in the absence of fetal breathing movements as they significantly alter venous velocities and waveform patterns.",
"   </p>",
"   <p>",
"    Color and pulsed wave Doppler are typically used in combination. Initially, color Doppler is employed to help identify vessels and assess the directionality and magnitude of flow. After the vessel portion with the highest magnitude of flow is thus identified, pulsed wave Doppler gate is placed at the desired site at the lowest angle of insonation that can be obtained. This technique yields flow velocity waveforms with a high signal to noise ratio and improves the accuracy and reproducibility of Doppler measurements [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although flow velocity waveforms have been reported for many venous vessels, the precordial veins (ductus venosus and inferior vena cava) and the umbilical vein are the vessels predominantly used in clinical practice. The following examination standards are recommended for each of these venous vessels:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The umbilical vein is best examined in a segment of free-floating umbilical cord.",
"     </li>",
"     <li>",
"      The ductus venosus can be examined in a longitudinal or transverse view of the upper abdomen. Color Doppler helps to identify the isthmus of this vessel. The isthmus is the smallest part of this trumpet-shaped vessel that also has the highest blood flow velocities.",
"     </li>",
"     <li>",
"      The IVC is best examined in a longitudinal plane that is parallel to the spine. In this plane, the IVC courses towards the right atrium. The highest interobserver agreement is achieved at the most distal sampling site. The ideal site is the portion of the vessel between the entry of the renal veins and the ductus venosus.",
"     </li>",
"     <li>",
"      The right and left hepatic veins are best examined in a transverse view of the liver, scanning from the left and the right, respectively. The middle hepatic vein may be examined in a transverse view scanning the liver from the front. Alternatively, a longitudinal view of the upper abdomen may be used.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DOPPLER ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler waveform analysis can be qualitative, quantitative, and semi-quantitative:",
"   </p>",
"   <p>",
"    Qualitative waveform analysis characterizes the flow velocity profile on purely descriptive terms. This is only utilized for the umbilical vein and the ductus venosus. Under normal circumstances blood flow in the umbilical vein is constant. Blood flow in the ductus venosus is antegrade throughout the cardiac cycle under physiologic conditions. In this vessel, absence or reversal of atrial-systolic forward flow is always abnormal.",
"   </p>",
"   <p>",
"    Quantitative waveform analysis allows measurement of actual blood flow volume. Because this technique requires close to 0 degree insonation and accurate measurement of the vessel diameter, it is too cumbersome for routine clinical use. Nevertheless, blood flow volume measurements in the umbilical vein are increasingly incorporated into perinatal practice because they can be more readily performed than for other vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Semiquantitative waveform analysis of venous vessels is based upon calculation of Doppler indices that reflect venous preload. The indices are ratios that incorporate various combinations of the following measurements obtained from the frequency shift envelope (",
"    <a class=\"graphic graphic_figure graphicRef79775 \" href=\"UTD.htm?26/48/27406\">",
"     figure 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Peak systolic frequency shift value (S)",
"     </li>",
"     <li>",
"      End-diastolic frequency shift value (D)",
"     </li>",
"     <li>",
"      Atrial systolic frequency shift value (a)",
"     </li>",
"     <li>",
"      Time averaged maximum frequency shift value during systole",
"     </li>",
"     <li>",
"      Time averaged maximum frequency shift value during diastole",
"     </li>",
"     <li>",
"      Time averaged maximum frequency shift value over one entire cardiac cycle",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Doppler indices such as the peak velocity index for veins (PVIV), pulsatility index for veins (PIV), and the percentage reverse flow, can be applied for all venous waveforms while individual preload indices have been described for the IVC and the ductus venosus.",
"   </p>",
"   <p>",
"    It has not been determined whether any particular index offers any advantage in clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/22\">",
"     22",
"    </a>",
"    ]. In this context, it is noteworthy that the PIV and PVIV reflect cardiac forward function as well as afterload, while the preload index for the IVC almost exclusively reflects cardiac function and is hardly influenced by afterload [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/23\">",
"     23",
"    </a>",
"    ]. The clinical significance of these different characteristics of individual venous indices is under ongoing investigation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Normative changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the umbilical vein pulsations are always seen at 8 weeks of gestation, but gradually decrease from 9 weeks of gestation onwards [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/24\">",
"     24",
"    </a>",
"    ]. This reflects increased cardiac contractility and compliance coupled with a successive decrease in placental afterload. Continuous forward flow without pulsations in the umbilical vein is established by 12 weeks of gestation in the majority of fetuses. Monophasic pulsatile flow in a free floating segment of the umbilical vein may be observed in up to 20 percent of normal fetuses in the third trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/25\">",
"     25",
"    </a>",
"    ]. These are a benign findings in the absence of any other signs of circulatory compromise. By comparison, multiphasic pulsations are not normal (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Abnormal profiles'",
"    </a>",
"    below)",
"   </p>",
"   <p>",
"    In the precordial veins all blood flow velocities increase significantly with advancing gestation. Forward velocities are highest in the ductus venosus ensuring that blood flow is always antegrade throughout the cardiac cycle. Peak velocities in this vessel increase from 65",
"    <span class=\"nowrap\">",
"     cm/s",
"    </span>",
"    at 18 weeks to 75",
"    <span class=\"nowrap\">",
"     cm/s",
"    </span>",
"    at term [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/11\">",
"     11",
"    </a>",
"    ]. Compared to the ductus venosus, forward velocities are lower in the IVC and lowest in the right hepatic vein. For this reason, atrial contraction may cause temporary reversal of forward flow in the IVC and almost always does so in the hepatic veins.",
"   </p>",
"   <p>",
"    Each of the central venous vessels has its own normative changes because of differences in absolute blood flow velocities. However, the ratio between S-wave and a-wave becomes smaller with advancing gestation in all central veins. Similarly, there is an increase in the time averaged maximum velocity of the entire venous waveform as well as the systolic and diastolic components. Consequently, the percentage of reverse flow and most other venous Doppler indices decrease with advancing gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/15,16,26\">",
"     15,16,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar to the physiologic disappearance of umbilical venous pulsations, the changes in venous Doppler indices reflect improved cardiac forward delivery of venous return. This is, in part, due to decreasing placental blood flow resistance (and therefore afterload) and to an increase in cardiac compliance and contractility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Abnormal profiles",
"    </span>",
"    &nbsp;&mdash;&nbsp;On qualitative waveforms analysis, biphasic or triphasic pulsations in the umbilical venous flow velocity profile and absence or reversal of the ductus venosus waveform are always abnormal (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef50745 \" href=\"UTD.htm?13/21/13654\">",
"     image 1",
"    </a>",
"    ). In the precordial veins, Doppler index elevation greater than two standard deviations (2 SD) from the gestational age mean is abnormal. While an isolated two SD Doppler index may be observed occasionally under normal circumstances, multiphasic umbilical venous pulsations or absent forward flow during atrial systole in the ductus venosus indicate significant elevation of central venous pressure and impaired cardiac preload handling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CLINICAL USES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Venous Doppler parameters may be abnormal due to several abnormalities in cardiovascular function. These include decreased cardiac compliance and contractility, marked elevations in cardiac afterload, and abnormalities of cardiac rhythm and rate. The clinical utility of venous Doppler velocimetry is therefore greatest in fetal conditions with cardiac manifestations",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    marked placental insufficiency. These conditions include fetal growth restriction due to placental insufficiency, twin-twin transfusion, fetal hydrops, and fetal arrhythmia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Fetal growth restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal growth restriction (FGR) due to placental insufficiency is most commonly due to abnormal vascular development of the placenta. Defective trophoblast invasion and failure of physiologic transformation of uterine vessels result in persistent uterine artery \"notching\"",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    elevation of the uterine artery Doppler index predisposing to progressive occlusive vasculopathy in the maternal and fetal vascular compartments of the placenta [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/27\">",
"     27",
"    </a>",
"    ]. Abnormal vascular tone, as well as obliterative loss of fetal villous vessels, raises umbilical artery Doppler resistance. A decrease in end-diastolic velocity becomes apparent when some 30 percent of placenta is affected and progresses to absent or reversed end-diastolic velocity when the damage extends to 60 to 70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/27\">",
"     27",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/30/10728?source=see_link\">",
"     \"Doppler ultrasound of the umbilical artery for fetal surveillance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Fetal cardiovascular manifestations are a prominent feature of this form of growth restriction. Because cardiovascular compromise progresses from arterial to venous flow, these changes have been termed early and late vascular responses, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Early Doppler changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of elevated placental blood flow resistance and impaired transplacental gas transfer has several effects:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Altered venous shunting across the ductus venosus increases the proportion of umbilical venous blood that bypasses the liver and reaches the left side of the heart through the foramen ovale [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/29,30\">",
"       29,30",
"      </a>",
"      ]. These adjustments in venous shunting follow a decline in umbilical venous volume flow",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      alterations in maternal nutrient status [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/31-33\">",
"       31-33",
"      </a>",
"      ]. This venous redistribution precedes lagging of abdominal circumference growth, which is one of the earliest physical manifestations of a decrease in liver size and growth delay [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/7,34\">",
"       7,34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Elevation of right ventricular afterload (placental resistance) forces redistribution of cardiac output towards the left ventricle and the relative proportion of left ventricular output rises. A decrease in the ratio between cerebral and umbilical artery Doppler indices (cerebroplacental Doppler ratio) is an early and sensitive marker of redistribution of cardiac output, often preceding overt growth delay by up to two weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/35\">",
"       35",
"      </a>",
"      ]. In this setting, the proportion of nutrient and oxygen-rich blood that is distributed to the heart and brain is increased.",
"     </li>",
"     <li>",
"      Several vascular beds may react to alterations in oxygen tension through autoregulation. A decrease in the middle cerebral artery Doppler index is direct evidence of \"brain sparing\" through autoregulation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/3\">",
"       3",
"      </a>",
"      ]. When the nadir of cerebral blood flow resistance is reached, aortic blood flow impedance increases [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/19,36\">",
"       19,36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These early vascular responses contribute to preferential perfusion of vital fetal organs and the placenta at the expense of less critical vascular beds of the bowel, lungs, and lower body.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Late Doppler changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Late Doppler changes generally accompany metabolic deterioration and are a result of declining forward cardiac function and abnormal organ autoregulation. Increasing venous Doppler indices are the hallmark of advancing circulatory deterioration since they document the decreasing ability of the heart to accommodate venous return [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Elevations of placental blood flow resistance and venous Doppler indices frequently progress in parallel.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Impaired preload and afterload handling can be documented in the precordial veins (ductus venosus, IVC, and SVC), the hepatic veins, and the head and neck veins (jugular vein and cerebral transverse sinus). Absence of umbilical artery end-diastolic velocity is characteristic in this setting.",
"     </li>",
"     <li>",
"      When fetal compromise accelerates, there is a further steady rise in umbilical blood flow resistance while venous Doppler indices escalate over a wide range [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/38\">",
"       38",
"      </a>",
"      ]. Atrial pressure waves may be transmitted all the way back into the free umbilical vein resulting in bi- and triphasic umbilical venous pulsations as the ultimate reflection of increased central venous pressure. Reversed umbilical artery end-diastolic velocity, overtly abnormal venous Doppler indices, and the development of oligohydramnios are characteristic manifestations of ineffective downstream delivery of cardiac output.",
"     </li>",
"     <li>",
"      Persistent excessive shunting across the ductus venosus compromises hepatic perfusion and may cause organ dysfunction and trigger hepatic artery vasodilatation as an alternative source of hepatic blood supply [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/39\">",
"       39",
"      </a>",
"      ]. Liver damage with elevated transaminases is an important contributor to metabolic deterioration under these circumstances.",
"     </li>",
"     <li>",
"      Coronary vasodilatation also becomes exaggerated in an attempt to recruit all the available coronary blood flow reserve [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/40\">",
"       40",
"      </a>",
"      ]. If this fails to support myocardial nutrition sufficiently, cardiac dysfunction may become critical. Cardiac dilatation with holosystolic tricuspid regurgitation and loss of cerebral autoregulation (normalizing cerebral Doppler indices) are observed at this level of compromise and indicate loss of cardiovascular homeostasis [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/36\">",
"       36",
"      </a>",
"      ]. If the fetus remains undelivered spontaneous late decelerations of the fetal heart rate and stillbirth ensue [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/41,42\">",
"       41,42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9921273\">",
"    <span class=\"h3\">",
"     Early versus late fetal growth restriction",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are important differences in the clinical and pathological findings observed in early versus late onset FGR. FGR diagnosed in the second trimester is associated with villous obliteration, early onset placental dysfunction, and early growth delay. It is characterized by progressive cardiovascular deterioration reflected by abnormal venous Doppler parameters and, eventually, deterioration of biophysical parameters. By comparison, FGR presenting in the third trimester is associated with a lesser degree of placental vascular abnormality and thus is not characterized by progressive deterioration to abnormal venous Doppler parameters. Instead, abnormal cerebral Doppler parameters are the leading cardiovascular sign of deterioration in late onset FGR [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/43-45\">",
"     43-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Implications for surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recognition of venous Doppler changes has led to reexamination of the relationship between prenatal Doppler findings in growth restricted fetuses and perinatal outcome. Historically, delivery has been recommended when umbilical artery Doppler end-diastolic velocities were absent or reversed. However, the growth restriction intervention trial (GRIT) indicated that in the subset of early onset FGR early and preterm delivery are independent risk factors for adverse neurodevelopment at two years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/46\">",
"     46",
"    </a>",
"    ]. Safe prolongation of pregnancy in these fetuses is therefore critical. Daily biophysical profile scoring in fetuses with absent or reversed umbilical artery end-diastolic velocity with strict delivery criteria has been associated with good outcome, suggesting that safe prolongation of these pregnancies is indeed possible [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23994?source=see_link\">",
"     \"Fetal growth restriction: Evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is now apparent that prediction of perinatal risks based on umbilical artery alone, without accounting for venous circulatory changes, is inadequate. Prediction of stillbirth and acidemia are significantly enhanced by addition of venous Doppler findings irrespective of the umbilical artery end-diastolic velocity [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/48,49\">",
"     48,49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preterm growth restricted fetuses with elevated umbilical artery Doppler resistance and positive end-diastolic velocity have an overall perinatal mortality rate of 5.6 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/49\">",
"     49",
"    </a>",
"    ]. This rate increases to 11.5 percent when end-diastolic velocity is absent or reversed, but venous Doppler indices are still normal, and rises to 38.8 percent when venous Doppler indices become abnormal (predominantly due to an increase in the rate of stillbirth). If the prevalence of stillbirth is 25 percent, abnormal venous Doppler findings have 65 percent sensitivity and 95 percent specificity in the prediction of stillbirth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/48\">",
"     48",
"    </a>",
"    ]. Depending on the cutoff (2 versus 3 SD) and the combination of veins examined, sensitivity for acidemia ranges from 70 to 90 percent and specificity from 70 to 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/17\">",
"     17",
"    </a>",
"    ]. However, a large observational study demonstrated the impact of gestational age on perinatal outcomes: neonatal survival in placenta-based FGR exceeded 50 percent only after 26 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/50\">",
"     50",
"    </a>",
"    ]. Ductus venosus Doppler parameters and cord pH had an independent impact on neonatal mortality and intact survival only beyond 28 weeks of gestation. Randomized trials testing the utility of venous Doppler in the management of preterm growth restricted fetuses are underway.",
"   </p>",
"   <p>",
"    Although Doppler ultrasonography and biophysical scoring both effectively stratify FGR fetuses into risk categories, the Doppler and biophysical scoring results do not always agree. The cardiovascular (Doppler) and behavioral (BPP) manifestations of fetal deterioration in FGR fetuses can occur largely independent of each other resulting in discordant Doppler and BPP findings [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/51\">",
"     51",
"    </a>",
"    ]. Management of these pregnancies needs to account for the obstetrical situation and gestational age; integration of multiple testing modalities provides the best prediction of acid base status at birth under these circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/52\">",
"     52",
"    </a>",
"    ]. The important differences in clinical presentation of early and late onset FGR need to be recognized in this context.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Twin to twin transfusion syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Twin to twin transfusion syndrome (TTTS) is a complication of monochorionic multiple gestation that results from unequal sharing of intravascular volume through communicating placental blood vessels. Differential blood flow across the placenta results in fetal size and amniotic fluid volume discordancies. This syndrome complicates approximately 10 to 15 percent of monochorionic pregnancies and often results in death of one or both fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28039?source=see_link\">",
"     \"Pathogenesis and diagnosis of twin-twin transfusion syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The introduction of Doppler velocimetry of the umbilical artery and the ductus venosus has clarified the range of placental and cardiovascular manifestations in TTTS and has been incorporated into the Quintero staging of this disorder. This staging system is based upon assessment of bladder filling as a marker of volume status, umbilical artery Doppler as a marker of placental blood flow resistance, and ductus venosus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    umbilical venous Doppler as a marker of cardiac forward function [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Stage 1 is defined by polyhydramnios (maximum pocket &gt;8 cm) and oligohydramnios (maximum pocket &lt;2 cm). Stage 2 is reached when bladder filling in the donor is no longer observed. Critically abnormal Doppler findings observed in either twin define stage 3 TTTS. These findings include absent umbilical artery end-diastolic velocity, absent forward flow during atrial systole in the ductus venosus or umbilical venous pulsations. Fetal hydrops define stage 4 while fetal death defines stage 5 of this syndrome.",
"   </p>",
"   <p>",
"    The introduction of this staging system unified the description of severe twin-to-twin transfusion, thereby facilitating both prognostic assessment in untreated pregnancies and comparison of outcomes from different therapies in similarly staged patients.",
"   </p>",
"   <p>",
"    We have studied umbilical vein flow in TTTS, as well, and found that it is significantly higher in recipients than in donors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/55\">",
"     55",
"    </a>",
"    ]. Intertwin differences in placental blood flow resistance and preload handling correlated negatively with the inequality of umbilical vein flow so that, with progression to advanced stage TTTS, the magnitude of umbilical vein flow that could be accommodated by the recipient declined. At this stage, small increments in umbilical vein flow appeared to trigger cardiovascular decompensation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Nonimmune hydrops",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetuses with nonimmune hydrops may have abnormal ventricular function, which can be documented by echocardiography showing an abnormal shortening fraction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/56\">",
"     56",
"    </a>",
"    ]. This impairment in cardiac function is also reflected in abnormal venous flow velocity waveforms. With marked elevations in central venous pressure, abnormal flow in the precordial veins may progress to the development of umbilical venous pulsations in a similar fashion to that described for FGR. The development of umbilical venous pulsations in hydropic fetuses is an ominous finding associated with demise in over 70 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/57\">",
"     57",
"    </a>",
"    ]. Therefore, we believe that venous Doppler should form part of the diagnostic assessment of nonimmune fetal hydrops. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34393?source=see_link\">",
"     \"Nonimmune hydrops fetalis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Fetal arrhythmia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of fetal heart rate and rhythm are grouped into tachy- and bradyarrhythmias. Diagnosis of a specific type of arrhythmia requires examination of the relationship between electrical and mechanical cardiac events. Classically this has been carried out using the time motion mode (M-Mode) of the ultrasound machine. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/40/24202?source=see_link\">",
"     \"Overview of the general approach to diagnosis and treatment of fetal cardiac arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An alternative method utilizes the Doppler technique to obtain simultaneous waveform recordings from an arterial and a venous vessel. This is possible at anatomic sites where arterial and venous vessels run in close proximity to each other such that the sample volume encompasses both vessels (eg, the aorta and inferior vena cava in the abdomen [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/58\">",
"     58",
"    </a>",
"    ], the jugular vein and carotid artery in the neck, the pulmonary artery and vein in the lung). When such a tracing is obtained, the relationship between the a-wave of the venous waveform and systolic pulse of the arterial waveform indicate the timing of the electrical events that correspond to the p wave and qrs complex of the ECG (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74469 \" href=\"UTD.htm?41/63/42992\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Venous Doppler is also useful in directing medical intervention in supraventricular tachycardia. In this type of arrhythmia, the normal triphasic venous waveform pattern is lost at heart rates in excess of 210 beats per minute and is replaced by a monophasic forward flow with reversal during atrial contraction. Above this critical heart rate, there is a 75 percent increase in central venous pressure that predisposes to the rapid progression of fetal hydrops [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prolonged supraventricular tachycardia is also associated with development of a reversible cardiomyopathy with ventricular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. The interindividual variations in cardiac dilatation, occurrence and timing of atrioventricular valve insufficiency, and resolution of hydrops are due to the severity of ventricular dysfunction. This is reflected in abnormal venous flow velocity waveforms that may persist for variable periods after cardioversion [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/63\">",
"     63",
"    </a>",
"    ]. Therefore, venous Doppler is an important adjunct in the direction of therapy and the monitoring of fetuses with this type of arrhythmia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/64,65\">",
"     64,65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     First trimester screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over the past decade, first trimester measurement of nuchal translucency (NT) thickness has evolved as one of the most sensitive and specific sonographic screening markers for Down syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/66\">",
"     66",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     Absent/reversed",
"    </span>",
"    atrial systolic velocities in the ductus venosus (DV-RAV) have been recognized as an important secondary ultrasound marker. In fetuses with abnormal NT, performance of ductus venosus Doppler increases sensitivity and decreases the false positive rate for the prediction of Down syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/67\">",
"     67",
"    </a>",
"    ]. DV-RAV is also seen in 1 to 5 percent of patients with a normal NT. Although 80 percent of these patients have normal outcomes, the rate of fetal cardiovascular anomalies, growth restriction and perinatal mortality is significantly increased [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14217/abstract/68,69\">",
"     68,69",
"    </a>",
"    ]. As discussed above, examinations using Doppler ultrasound in the first trimester of pregnancy should be restricted to proven medically-indicated diagnostic purposes because of the risk of temperature elevation in insonated tissue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=see_link\">",
"     \"Sonographic findings associated with fetal aneuploidy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Doppler velocimetry of the fetal venous circulation provides a noninvasive measure of forward cardiac function and, to a lesser degree, cardiac afterload.",
"     </li>",
"     <li>",
"      The normal venous flow velocity profile is triphasic reflecting pressure volume changes in the atria. The three phases are systole (S-wave), diastole (D-wave) and atrial systole (a-wave).",
"     </li>",
"     <li>",
"      Venous Doppler velocimetry is complementary to arterial Doppler in all fetal diseases that are potentially associated with cardiac dysfunction.",
"     </li>",
"     <li>",
"      Biphasic and triphasic umbilical venous pulsations and absence or reversal of atrial systolic velocities in the ductus venosus are always abnormal. Abnormal venous flow is also reflected in Doppler index elevation greater than two standard deviations from the gestational age mean.",
"     </li>",
"     <li>",
"      Venous Doppler is predominantly utilized in the management of growth restriction due to placental insufficiency, twin-to-twin transfusion syndrome, fetal hydrops, and fetal arrhythmia.",
"     </li>",
"     <li>",
"      In growth restricted fetuses, venous Doppler abnormalities constitute a late circulatory finding. The use of venous Doppler appears to significantly improve the prediction of stillbirth and acidemia over use of umbilical artery Doppler alone. Randomized trials to asses the role of venous Doppler in delivery timing are underway.",
"     </li>",
"     <li>",
"      In twin-twin transfusion syndrome venous Doppler velocimetry is part of a clinical staging system that has diagnostic and prognostic significance.",
"     </li>",
"     <li>",
"      In fetal hydrops the presence of umbilical venous pulsations is associated with a high risk of perinatal death.",
"     </li>",
"     <li>",
"      Venous Doppler velocimetry can be used for the diagnosis of fetal arrhythmia. In fetuses with supraventricular tachycardia, it is of diagnostic and prognostic value because resolution of tachycardia induced cardiomyopathy can be monitored.",
"     </li>",
"     <li>",
"      First trimester ductus venosus Doppler is an important adjunct to nuchal translucency screening, as it helps to stratify risks for chromosomal abnormalities, cardiac defects, fetal growth restriction and perinatal mortality independently of the nuchal translucency thickness. Examinations using Doppler ultrasound in the first trimester of pregnancy should be restricted to proven medically-indicated diagnostic purposes because of the risk of temperature elevation in insonated tissue.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/1\">",
"      FitzGerald DE, Drumm JE. Non-invasive measurement of human fetal circulation using ultrasound: a new method. Br Med J 1977; 2:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/2\">",
"      Eik-Nes SH, Marsal K, Brubakk AO, et al. Ultrasonic measurement of human fetal blood flow. J Biomed Eng 1982; 4:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/3\">",
"      Wladimiroff JW, Tonge HM, Stewart PA. Doppler ultrasound assessment of cerebral blood flow in the human fetus. Br J Obstet Gynaecol 1986; 93:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/4\">",
"      Kirkinen P, Jouppila P, Eik-Nes S. Umbilical venous flow as indicator of fetal anaemia. Lancet 1981; 1:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/5\">",
"      Gill RW, Trudinger BJ, Garrett WJ, et al. Fetal umbilical venous flow measured in utero by pulsed Doppler and B-mode ultrasound. I. Normal pregnancies. Am J Obstet Gynecol 1981; 139:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/6\">",
"      Griffin D, Cohen-Overbeek T, Campbell S. Fetal and utero-placental blood flow. Clin Obstet Gynaecol 1983; 10:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/7\">",
"      Baschat AA. The fetal circulation and essential organs-a new twist to an old tale. Ultrasound Obstet Gynecol 2006; 27:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/8\">",
"      Kiserud T, Acharya G. The fetal circulation. Prenat Diagn 2004; 24:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/9\">",
"      Huisman TW, Gittenberger-de Groot AC, Wladimiroff JW. Recognition of a fetal subdiaphragmatic venous vestibulum essential for fetal venous Doppler assessment. Pediatr Res 1992; 32:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/10\">",
"      CHACKO AW, REYNOLDS SR. Embryonic development in the human of the sphincter of the ductus venosus. Anat Rec 1953; 115:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/11\">",
"      Kiserud T. The ductus venosus. Semin Perinatol 2001; 25:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/12\">",
"      Kiserud T, Ebbing C, Kessler J, Rasmussen S. Fetal cardiac output, distribution to the placenta and impact of placental compromise. Ultrasound Obstet Gynecol 2006; 28:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/13\">",
"      Kiserud T, Rasmussen S, Skulstad S. Blood flow and the degree of shunting through the ductus venosus in the human fetus. Am J Obstet Gynecol 2000; 182:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/14\">",
"      Huisman TW, Stewart PA, Wladimiroff JW, Stijnen T. Flow velocity waveforms in the ductus venosus, umbilical vein and inferior vena cava in normal human fetuses at 12-15 weeks of gestation. Ultrasound Med Biol 1993; 19:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/15\">",
"      Hecher K, Campbell S, Snijders R, Nicolaides K. Reference ranges for fetal venous and atrioventricular blood flow parameters. Ultrasound Obstet Gynecol 1994; 4:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/16\">",
"      Kanzaki T, Chiba Y. Evaluation of the preload condition of the fetus by inferior vena caval blood flow pattern. Fetal Diagn Ther 1990; 5:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/17\">",
"      Rizzo G, Capponi A, Talone PE, et al. Doppler indices from inferior vena cava and ductus venosus in predicting pH and oxygen tension in umbilical blood at cordocentesis in growth-retarded fetuses. Ultrasound Obstet Gynecol 1996; 7:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/18\">",
"      Weiner Z, Goldberg Y, Shalev E. Internal jugular vein blood flow in normal and growth-restricted fetuses. Obstet Gynecol 2000; 96:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/19\">",
"      Senat MV, Schw&auml;rzler P, Alcais A, Ville Y. Longitudinal changes in the ductus venosus, cerebral transverse sinus and cardiotocogram in fetal growth restriction. Ultrasound Obstet Gynecol 2000; 16:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/20\">",
"      Londrey GL, Spadone DP, Hodgson KJ, et al. Does color-flow imaging improve the accuracy of duplex carotid evaluation? J Vasc Surg 1991; 13:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/21\">",
"      Barbera A, Galan HL, Ferrazzi E, et al. Relationship of umbilical vein blood flow to growth parameters in the human fetus. Am J Obstet Gynecol 1999; 181:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/22\">",
"      Baschat AA, G&uuml;cl&uuml; S, Kush ML, et al. Venous Doppler in the prediction of acid-base status of growth-restricted fetuses with elevated placental blood flow resistance. Am J Obstet Gynecol 2004; 191:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/23\">",
"      Baschat AA. Relationship between placental blood flow resistance and precordial venous Doppler indices. Ultrasound Obstet Gynecol 2003; 22:561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/24\">",
"      Rizzo G, Arduini D, Romanini C. Umbilical vein pulsations: a physiologic finding in early gestation. Am J Obstet Gynecol 1992; 167:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/25\">",
"      van Splunder IP, Huisman TW, Stijnen T, Wladimiroff JW. Presence of pulsations and reproducibility of waveform recording in the umbilical and left portal vein in normal pregnancies. Ultrasound Obstet Gynecol 1994; 4:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/26\">",
"      Rizzo G, Capponi A, Arduini D, Romanini C. Ductus venosus velocity waveforms in appropriate and small for gestational age fetuses. Early Hum Dev 1994; 39:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/27\">",
"      Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol 2004; 28:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/28\">",
"      Ferrazzi E, Bozzo M, Rigano S, et al. Temporal sequence of abnormal Doppler changes in the peripheral and central circulatory systems of the severely growth-restricted fetus. Ultrasound Obstet Gynecol 2002; 19:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/29\">",
"      Baschat AA. Fetal responses to placental insufficiency: an update. BJOG 2004; 111:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/30\">",
"      Tchirikov M, Schr&ouml;der HJ, Hecher K. Ductus venosus shunting in the fetal venous circulation: regulatory mechanisms, diagnostic methods and medical importance. Ultrasound Obstet Gynecol 2006; 27:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/31\">",
"      Rigano S, Bozzo M, Ferrazzi E, et al. Early and persistent reduction in umbilical vein blood flow in the growth-restricted fetus: a longitudinal study. Am J Obstet Gynecol 2001; 185:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/32\">",
"      Bellotti M, Pennati G, De Gasperi C, et al. Simultaneous measurements of umbilical venous, fetal hepatic, and ductus venosus blood flow in growth-restricted human fetuses. Am J Obstet Gynecol 2004; 190:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/33\">",
"      Haugen G, Hanson M, Kiserud T, et al. Fetal liver-sparing cardiovascular adaptations linked to mother's slimness and diet. Circ Res 2005; 96:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/34\">",
"      Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol 2008; 32:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/35\">",
"      Harrington K, Thompson MO, Carpenter RG, et al. Doppler fetal circulation in pregnancies complicated by pre-eclampsia or delivery of a small for gestational age baby: 2. Longitudinal analysis. Br J Obstet Gynaecol 1999; 106:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/36\">",
"      Arduini D, Rizzo G, Romanini C. Changes of pulsatility index from fetal vessels preceding the onset of late decelerations in growth-retarded fetuses. Obstet Gynecol 1992; 79:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/37\">",
"      Hecher K, Campbell S. Characteristics of fetal venous blood flow under normal circumstances and during fetal disease. Ultrasound Obstet Gynecol 1996; 7:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/38\">",
"      Hecher K, Campbell S, Doyle P, et al. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies. Circulation 1995; 91:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/39\">",
"      Kilavuz O, Vetter K. Is the liver of the fetus the 4th preferential organ for arterial blood supply besides brain, heart, and adrenal glands? J Perinat Med 1999; 27:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/40\">",
"      Baschat AA, Gembruch U, Reiss I, et al. Demonstration of fetal coronary blood flow by Doppler ultrasound in relation to arterial and venous flow velocity waveforms and perinatal outcome--the 'heart-sparing effect'. Ultrasound Obstet Gynecol 1997; 9:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/41\">",
"      Rizzo G, Arduini D. Fetal cardiac function in intrauterine growth retardation. Am J Obstet Gynecol 1991; 165:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/42\">",
"      Rizzo G, Capponi A, Pietropolli A, et al. Fetal cardiac and extracardiac flows preceding intrauterine death. Ultrasound Obstet Gynecol 1994; 4:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/43\">",
"      Bahado-Singh RO, Kovanci E, Jeffres A, et al. The Doppler cerebroplacental ratio and perinatal outcome in intrauterine growth restriction. Am J Obstet Gynecol 1999; 180:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/44\">",
"      Hecher K, Bilardo CM, Stigter RH, et al. Monitoring of fetuses with intrauterine growth restriction: a longitudinal study. Ultrasound Obstet Gynecol 2001; 18:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/45\">",
"      Turan OM, Turan S, Gungor S, et al. Progression of Doppler abnormalities in intrauterine growth restriction. Ultrasound Obstet Gynecol 2008; 32:160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/46\">",
"      Thornton JG, Hornbuckle J, Vail A, et al. Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial. Lancet 2004; 364:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/47\">",
"      Divon MY, Girz BA, Lieblich R, Langer O. Clinical management of the fetus with markedly diminished umbilical artery end-diastolic flow. Am J Obstet Gynecol 1989; 161:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/48\">",
"      Baschat AA, Gembruch U, Weiner CP, Harman CR. Qualitative venous Doppler waveform analysis improves prediction of critical perinatal outcomes in premature growth-restricted fetuses. Ultrasound Obstet Gynecol 2003; 22:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/49\">",
"      Baschat AA. Doppler application in the delivery timing of the preterm growth-restricted fetus: another step in the right direction. Ultrasound Obstet Gynecol 2004; 23:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/50\">",
"      Baschat AA, Cosmi E, Bilardo CM, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol 2007; 109:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/51\">",
"      Baschat AA, Galan HL, Bhide A, et al. Doppler and biophysical assessment in growth restricted fetuses: distribution of test results. Ultrasound Obstet Gynecol 2006; 27:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/52\">",
"      Turan S, Turan OM, Berg C, et al. Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid-base status of growth-restricted fetuses. Ultrasound Obstet Gynecol 2007; 30:750.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/53\">",
"      Duncan KR, Denbow ML, Fisk NM. The aetiology and management of twin-twin transfusion syndrome. Prenat Diagn 1997; 17:1227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/54\">",
"      Quintero RA, Morales WJ, Allen MH, et al. Staging of twin-twin transfusion syndrome. J Perinatol 1999; 19:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/55\">",
"      Gungor S, Glosemeyer P, Huber A, et al. Umbilical venous volume flow in twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2008; 32:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/56\">",
"      Gudmundsson S, Huhta JC, Wood DC, et al. Venous Doppler ultrasonography in the fetus with nonimmune hydrops. Am J Obstet Gynecol 1991; 164:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/57\">",
"      Tulzer G, Gudmundsson S, Wood DC, et al. Doppler in non-immune hydrops fetalis. Ultrasound Obstet Gynecol 1994; 4:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/58\">",
"      Chan FY, Woo SK, Ghosh A, et al. Prenatal diagnosis of congenital fetal arrhythmias by simultaneous pulsed Doppler velocimetry of the fetal abdominal aorta and inferior vena cava. Obstet Gynecol 1990; 76:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/59\">",
"      Gest AL, Martin CG, Mo&iuml;se AA, Hansen TN. Reversal of venous blood flow with atrial tachycardia and hydrops in fetal sheep. Pediatr Res 1990; 28:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/60\">",
"      Gembruch U, Krapp M, Baumann P. Changes of venous blood flow velocity waveforms in fetuses with supraventricular tachycardia. Ultrasound Obstet Gynecol 1995; 5:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/61\">",
"      Damiano RJ Jr, Tripp HF Jr, Asano T, et al. Left ventricular dysfunction and dilatation resulting from chronic supraventricular tachycardia. J Thorac Cardiovasc Surg 1987; 94:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/62\">",
"      Spinale FG, Crawford FA Jr, Hewett KW, Carabello BA. Ventricular failure and cellular remodeling with chronic supraventricular tachycardia. J Thorac Cardiovasc Surg 1991; 102:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/63\">",
"      Krapp M, Gembruch U, Baumann P. Venous blood flow pattern suggesting tachycardia-induced 'cardiomyopathy' in the fetus. Ultrasound Obstet Gynecol 1997; 10:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/64\">",
"      Krapp M, Baschat AA, Gembruch U, et al. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol 2002; 19:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/65\">",
"      Fouron JC. Fetal arrhythmias: the Saint-Justine hospital experience. Prenat Diagn 2004; 24:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/66\">",
"      Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004; 191:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/67\">",
"      Borrell A, Antolin E, Costa D, et al. Abnormal ductus venosus blood flow in trisomy 21 fetuses during early pregnancy. Am J Obstet Gynecol 1998; 179:1612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/68\">",
"      Oh C, Harman C, Baschat AA. Abnormal first-trimester ductus venosus blood flow: a risk factor for adverse outcome in fetuses with normal nuchal translucency. Ultrasound Obstet Gynecol 2007; 30:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14217/abstract/69\">",
"      Maiz N, Valencia C, Emmanuel EE, et al. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation. Obstet Gynecol 2008; 112:598.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 432 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-197.136.42.3-93F80B87AB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14217=[""].join("\n");
var outline_f13_56_14217=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      FETAL CIRCULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Venous anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Differential blood flow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Distribution of cardiac output",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Atrial pressure changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Ventricular systole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Early ventricular diastole",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Atrial systole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Venous flow velocity waveforms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DOPPLER ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Normative changes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Abnormal profiles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CLINICAL USES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Fetal growth restriction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Early Doppler changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Late Doppler changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9921273\">",
"      - Early versus late fetal growth restriction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Implications for surveillance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Twin to twin transfusion syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Nonimmune hydrops",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Fetal arrhythmia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      First trimester screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/432\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/432|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/21/13654\" title=\"diagnostic image 1\">",
"      Progressive doppler abnormality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/63/42992\" title=\"diagnostic image 2\">",
"      Fetal 2nd degree AV block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/432|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/43/15032\" title=\"figure 1\">",
"      Fetal circulation 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/39/10864\" title=\"figure 2\">",
"      Fetal cardiac output distributi",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/22/15726\" title=\"figure 3\">",
"      Venous Doppler waveforms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/48/27406\" title=\"figure 4\">",
"      Doppler indices of venous flow",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/432|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?14/30/14823\" title=\"waveform 1\">",
"      Anatomic sites with waveform",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/30/10728?source=related_link\">",
"      Doppler ultrasound of the umbilical artery for fetal surveillance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23994?source=related_link\">",
"      Fetal growth restriction: Evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/37/34393?source=related_link\">",
"      Nonimmune hydrops fetalis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/40/24202?source=related_link\">",
"      Overview of the general approach to diagnosis and treatment of fetal cardiac arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28039?source=related_link\">",
"      Pathogenesis and diagnosis of twin-twin transfusion syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/41/22170?source=related_link\">",
"      Sonographic findings associated with fetal aneuploidy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_56_14218="Congenital and pediatric coronary artery abnormalities";
var content_f13_56_14218=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Congenital and pediatric coronary artery abnormalities",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14218/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14218/contributors\">",
"     Peter R Koenig, MD, FACC, FASE",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14218/contributors\">",
"     Ziyad M Hijazi, MD, MPH, FAAP, FACC, FSCAI, FAHA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14218/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14218/contributors\">",
"     Thomas P Graham, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14218/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/56/14218/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/56/14218/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/56/14218/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In early fetal development, the primitive loosely packed myocardium is nourished via sinusoids, which communicate with the heart cavities. Persistence of these sinusoids may lead to coronary artery cameral fistulae. As the myocardium becomes more compact, the sinusoids disappear and give rise to a network of veins, arteries, and capillaries (at approximately 32 days of gestation) that may have connections with other mediastinal vessels. Persistence of these connections may lead to coronary artery fistulae. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Persistent sinusoids'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As the coronary artery network evolves, endothelial buds arise from the base of the truncus arteriosus. It is still unknown if initially there are only two buds, or buds from each potential cusp of the aortic and pulmonary sinuses (six buds) with later involution of all but two buds. These buds later grow and join the coronary artery network that develops from the sinusoids to establish the definitive coronary artery system. Abnormal involution (in the case of six initial buds), bud position, or septation of the truncus arteriosus may lead to the development of an abnormal origin of the coronary arteries.",
"   </p>",
"   <p>",
"    Given this complex embryology, it is expected that deviations in development may result in various (\"abnormal\") origins of the coronary arteries from the normal sinuses of Valsalva in the aorta or from the pulmonary artery. Some of these variations may have no clinical importance while others are clearly pathologic. These variations can be associated with underlying congenital heart defects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     VARIATIONS OF CORONARY ARTERY ORIGIN FROM THE AORTA",
"    </span>",
"    &nbsp;&mdash;&nbsp;In otherwise normal patients, there may be variations in the number, shape, and location of the ostia or origins of the coronary arteries. Most of these variations appear to be of no clinical significance [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/1\">",
"     1",
"    </a>",
"    ], although a high origin of the ostia may reduce diastolic coronary artery blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Separate origins of the right coronary artery (RCA) and its conal branch occur in 50 percent of the population and separate origins of the left circumflex coronary artery (LCx) and left anterior descending artery (LAD) in 1 percent.",
"   </p>",
"   <p>",
"    More important lesions include origin of the left main coronary artery or LAD from the right sinus of Valsalva or RCA, referred to as anomalous aortic origin of a coronary artery (AAOCA). The subsequent course between the aorta and pulmonary artery to the left ventricle may result in compression of the vessel, myocardial ischemia, and sudden death in both adults and teenagers [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. Alternatively, it may be the intramural course and acute angle of takeoff which may predispose to obstruction to blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/5\">",
"     5",
"    </a>",
"    ]. In one study, the length of the intramural course was found to correlate with symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/6\">",
"     6",
"    </a>",
"    ]. Complications",
"    <strong>",
"    </strong>",
"    commonly occur during or immediately after exercise, though sudden death may occur without prior symptoms. It has been proposed that exercise leads to expansion of the aortic root and pulmonary trunk, which, in addition to external coronary artery compression, may increase the preexisting angulation of the coronary artery takeoff, reducing the luminal diameter in the proximal portion of the coronary artery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, a single coronary artery originating from the right sinus of Valsalva may result in compression of the LAD or its branches via the same mechanism. Origin of the RCA from the left sinus of Valsalva or LAD also can lead to myocardial ischemia and sudden death [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, origin of the LCx from the RCA is generally felt to be of no clinical significance due to its posterior course to the left ventricle. However, it is possible that vascular compression can occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Incidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of abnormal aortic origin of the coronary arteries is low with reported values of approximately 0.64 percent of births [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/8\">",
"     8",
"    </a>",
"    ] and 0.17 percent in asymptomatic children and adolescents who were referred for and underwent echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/9\">",
"     9",
"    </a>",
"    ]. The most common anomaly is the left circumflex from the right sinus of Valsalva, followed by a single coronary artery from the left sinus of Valsalva, both coronary arteries from the right sinus of Valsalva, and the LAD from the right sinus of Valsalva. The prevalence of either the right coronary artery arising from the left sinus of Valsalva or the left main coronary artery arising from the right sinus of Valsalva is between 0.1 and 0.3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/10\">",
"     10",
"    </a>",
"    ]. The prevalence of the RCA arising from the left sinus of Valsalva is greater than the LCA from the right sinus of Valsalva, 0.17 percent versus 0.047 percent though both are uncommon [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation of a patient with the above mentioned abnormalities may be anginal chest pain, or syncope, especially with exercise. Unfortunately, the first clinical symptom may be sudden death, particularly in young athletes and military recruits [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. In a registry of sudden death in 286 competitive athletes under age 35 in whom cardiovascular disease was shown to be the cause at autopsy, an anomalous coronary artery of wrong sinus origin was responsible for 13 percent of cases, being second in frequency to hypertrophic cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/13\">",
"     13",
"    </a>",
"    ]. In a series of autopsies in military recruits, an anomalous coronary artery was the most frequent cause of sudden cardiac death [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=see_link\">",
"     \"Risk of sudden cardiac death in athletes\"",
"    </a>",
"    .). Overall, the incidence of sudden death in patients with AAOCA is low, though higher for patients with AAOCA of the LCA than with AAOCA of the RCA, especially in the absence of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical examination and diagnostic studies are usually unrevealing in the absence of myocardial infarction or symptoms of ongoing ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/3,16\">",
"     3,16",
"    </a>",
"    ]. When anomalous origin of a coronary artery is suspected, echocardiography may establish the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/17\">",
"     17",
"    </a>",
"    ]. However, noninvasive coronary magnetic resonance angiography (CMRA) is increasingly used to define anomalous coronary anatomy. Coronary angiography, which was the historical gold standard for the evaluation of the origin and course of the coronary arteries, is still recommended when other studies are not diagnostic [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The ability of CMRA to reliably identify the proximal course of the major coronary arteries and the desire to minimize radiation exposure makes this an ideal procedure to image young adults with suspected coronary anomalies. Coronary angiography by computed tomography is a noninvasive alternative to CMRA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20906?source=see_link\">",
"     \"Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The efficacy of CMRA has been evaluated in a number of small studies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. The following observations illustrate the typical findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report of 19 patients with anomalous coronary arteries in whom CMRA and conventional x-ray coronary angiography were performed, there was close agreement in findings with the two tests [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/20\">",
"       20",
"      </a>",
"      ]. In the three cases in which the two modalities disagreed, the CMRA gave a clearer result than the x-ray image.",
"     </li>",
"     <li>",
"      In a series of 16 patients with anomalous coronaries, CMRA had a sensitivity of 88 percent, and a specificity of 100 percent using the x-ray image as the gold standard [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/21\">",
"       21",
"      </a>",
"      ]. It was suggested that the combination of the two studies improves the definition of the course of the proximal anomalous artery: CMRA provides better spatial relationships, while conventional coronary angiography permits a view of the entire length of the artery and its peripheral runoff.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Coronary computed tomography angiography (CCTA) can be performed with electron beam or multidetector row (multislice) scanners; the latter are much more widely available [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. The potential efficacy of CCTA was illustrated in a study of 17 patients who were referred because of equivocal findings at cardiac catheterization or echocardiography [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/23\">",
"     23",
"    </a>",
"    ]. Multidetector row CCTA provided an accurate depiction of the origin and course of 20 anomalous arteries in these patients.",
"   </p>",
"   <p>",
"    In general, with the rapid refinement of both CMRA and CCTA, most coronary artery abnormalities can be imaged equally well; one modality may be better than the other for a time pending refinements in which it is equaled or bested by the other. The major considerations in choosing one or the other include time (CMRA taking longer than a CCTA, though the difference is becoming less as CMRA becomes faster), radiation used for CCTA, and the contraindication to CMRA in some patients because of implanted devices and metal objects.",
"   </p>",
"   <p>",
"    Other imaging studies may be of some benefit. Stress studies (echocardiography or radionuclide myocardial perfusion imaging) may aid in the management of coronary artery variations, including a superior location of the coronary ostia, if it is unclear whether there is a risk of ischemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical intervention is indicated for coronary artery abnormalities in symptomatic patients with AAOCA (particularly with origin of the LCA from the right sinus), such as those with serious ventricular tachyarrhythmias or documented myocardial ischemia. There are no controlled studies which have evaluated the outcome of intervention in asymptomatic individuals.",
"   </p>",
"   <p>",
"    The indications for intervention in asymptomatic patients with AAOCA with an intramural course are debated, especially with AAOCA RCA from the left sinus of Valsalva [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/10,15\">",
"     10,15",
"    </a>",
"    ]. Our authors and reviewers generally refer asymptomatic patients with left coronary artery arising from the right coronary sinus for surgical repair.",
"   </p>",
"   <p>",
"    Asymptomatic patients with the right coronary artery arising from the left sinus are managed on a case by case basis by our authors and reviewers, with factors such as surgical risk, longevity, and patient preference taken into account. Factors that might be taken into account in the decision regarding prophylactic surgery might include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The finding of exercise induced myocardial ischemia found on screening with stress testing in these patients [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/15\">",
"       15",
"      </a>",
"      ]. However, in one study, it was found that signs of ischemia on stress testing were higher postoperatively than preoperatively, especially patients with a RCA from the left sinus of Valsalva [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 2011 study reported on the medium-term results after surgical repair in 50 patients with AAOCA, 31 of whom had the RCA originating from the left sinus of valsalva. There was no operative mortality and there were no deaths with an average duration of flow-up of 5.5 years [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prevalence of AAOCA without an intramural course is not known, in part due to the lack of study of this issue using high resolution imaging techniques. Based on anecdotal information, an intramural course of the coronary artery is likely in all cases of AAOCA, but the length of the intramural course may vary.",
"   </p>",
"   <p>",
"    Surgical interventions can consist of coronary artery bypass grafting (CABG) or unroofing (marsupialization) of the coronary artery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/28\">",
"     28",
"    </a>",
"    ] to prevent compression from a change in the angulation. The &ldquo;hinge-twist&rdquo; procedure has been described for AAOCA without an intramural course [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/29\">",
"     29",
"    </a>",
"    ], and a pulmonary artery translocation technique has been described for a single coronary ostium without an intramural course [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/30\">",
"     30",
"    </a>",
"    ]. Intracoronary stents have also been used as an alternative to CABG in symptomatic patients with ischemia; their structural rigidity may protect the vessel against compression [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Association with other congenital heart diseases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Variations in origin of the coronary arteries from the aorta are commonly seen with congenital heart diseases such as tetralogy of Fallot, transposition of the great arteries, double outlet right ventricle, univentricular hearts, and truncus arteriosus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Tetralogy of Fallot",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anomalous origin of the coronary arteries occurs in approximately 9 percent of patients with tetralogy of Fallot [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. The most common variations are an enlarged conal artery, an anomalous LAD arising from the RCA or right sinus of Valsalva, and a single coronary artery. These variations are important to recognize for surgical repair, as the coronary arteries may be vulnerable to injury during right ventricular outflow tract reconstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28794?source=see_link\">",
"     \"Overview of the management of tetralogy of Fallot\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Transposition of the great arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of coronary anomalies are seen in patients with D-transposition of the great arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common, occurring in about 60 percent of patients, is origin of the RCA from the posterior aspect of the right-facing sinus of Valsalva and the left main coronary artery from the posterior aspect of the left-facing sinus.",
"     </li>",
"     <li>",
"      The next most common abnormality, seen in about 20 percent, is an LCx arising from the RCA.",
"     </li>",
"     <li>",
"      Other lesions, each occurring in 3 to 9 percent of patients, include coronary artery inversion (ie, the RCA arising from the left posterior sinus of Valsalva and the left main coronary artery arising from the right posterior sinus of Valsalva), inversion of the coronary arteries with the LCx artery arising from the RCA, and single coronary artery, arising from either the right or left sinus of Valsalva.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An intramural rather than epicardial course of any of the coronary arteries may be seen in D-transposition. Since coronary artery reimplantation is part of the repair of D-transposition of the great arteries, knowledge of the coronary artery pattern is important.",
"   </p>",
"   <p>",
"    In L-transposition of the great arteries, there is confusion in the nomenclature of the coronary arteries, since they may be named for the sinus of Valsalva from which they originate or the ventricle that they supply [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/1,35-38\">",
"     1,35-38",
"    </a>",
"    ]. Using the convention of naming from the sinus of origin, the RCA supplies the right-sided left ventricle and branches into an LCx and LAD branch the way a left coronary artery usually does. The left coronary artery takes a course similar to the usual RCA in the interventricular groove.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Truncus arteriosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;In truncus arteriosus, the usual coronary artery pattern is present unless more than three cusps are present. In this setting, variations can occur, which may lead to injury during surgical procedures, including coronary arteries that course over the anterior surface of the right ventricle (predisposing to coronary artery injury during surgical procedures), a single coronary artery, or displacement of the coronary ostia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/38-40\">",
"     38-40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other congenital heart defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other congenital heart defects, such as a univentricular heart, have coronary artery patterns similar to those described above depending upon the relationship of the great arteries to each other and the outflow chambers. The coronary artery variations may be diagnosed prior to surgery with echocardiography or ultrafast CT in some centers, although angiography remains the gold standard.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of the above variations depends upon the exact nature of the lesion. Many of the variations, especially if the origin is from the aorta, do not require surgical correction if there is no evidence for ongoing or predicted development of myocardial ischemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     VARIATIONS OF CORONARY ARTERY ORIGIN FROM THE PULMONARY ARTERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;An anomalous origin of one or more coronary arteries from the pulmonary artery is usually an isolated abnormality, occurring in 0.4 percent of patients with congenital cardiac abnormalities (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62373 \" href=\"UTD.htm?41/45/42706\">",
"     image 1",
"    </a>",
"    ). Such lesions are hemodynamically significant and produce myocardial ischemia that may be progressive and lead to ischemic cardiomyopathy. The following mechanisms may be involved:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The myocardium is perfused by the abnormally arising coronary artery, which has a relatively low perfusion pressure and carries blood with a low oxygen saturation, reflecting the pulmonary artery source.",
"     </li>",
"     <li>",
"      In the presence of collateral circulation from a normally arising coronary artery, there will be coronary artery steal, as flow will be directed from the normal coronary artery to the pulmonary artery, ie, a left to right shunt, via the collateral vessels [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/41,42\">",
"       41,42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The most common defect of this type is origin of the LCA from the pulmonary artery, sometimes known as Bland-White-Garland syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. In some cases, the LAD and LCx coronary arteries have individual origins from the pulmonary artery, with similar pathophysiologic and clinical sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. The origin of the RCA from the pulmonary artery has been thought to be benign, however, clinical sequelae have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Clinical presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical presentation varies with the coronary artery involved and its myocardial distribution, the pulmonary vascular resistance, and the number and size of collateral vessels.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Without significant collateral blood supply, myocardial ischemia in the region supplied by the abnormal coronary artery will occur in infancy when the neonatal elevated pulmonary vascular resistance normalizes. With the onset of ischemia, myocardial function deteriorates with the associated signs and symptoms of heart failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=see_link\">",
"       \"Evaluation of the patient with suspected heart failure\"",
"      </a>",
"      .) In neonates, angina may manifest as irritability, pallor, and diaphoresis, with progression to signs and symptoms of shock. These findings usually become apparent at four to six weeks of age when the pulmonary vascular resistance has decreased, though the presentation may be delayed.",
"     </li>",
"     <li>",
"      With good collateral blood flow, the presentation of this abnormality may be delayed to later childhood, teen or even adult age [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/1\">",
"       1",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8216?source=see_link\">",
"       \"Coronary collateral circulation\"",
"      </a>",
"      .) Older children and adults may present with findings of a dilated cardiomyopathy or sudden death.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other than physical signs of shock, important physical findings include a gallop or a murmur of mitral regurgitation, reflecting papillary muscle dysfunction due to ischemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    .) A continuous murmur resembling a patent ductus arteriosus, with flow from the aorta to the pulmonary circulation, may be noted, reflecting flow through collaterals. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=see_link\">",
"     \"Clinical manifestations and diagnosis of patent ductus arteriosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Chest x-ray and electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chest x-ray may show cardiomegaly",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary edema. The electrocardiogram of an infant with an anomalous left coronary artery from the pulmonary artery shows evidence for anterolateral ischemia or infarction, including transient or chronic ST-segment changes in the anterolateral leads or Q waves in leads I avL, V5, and V6 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/49\">",
"     49",
"    </a>",
"    ]. However, 20 to 45 percent of patients do not have abnormal Q waves. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=see_link&amp;anchor=H16#H16\">",
"     \"Electrocardiogram in the diagnosis of myocardial ischemia and infarction\", section on 'Anterior MI'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Noninvasive imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography typically demonstrates a dilated heart with global myocardial dysfunction and associated mitral regurgitation. Echogenic papillary muscles and endocardial borders are frequently noted. The abnormal coronary artery origins and associated dilation due to shunting or runoff should be apparent with two-dimensional imaging, although color Doppler may provide additional evidence of this diagnosis by showing the abnormal direction of coronary blood flow. Noninvasive imaging with either cardiac computed tomography angiography (CCTA) or cardiac magnetic resonance angiography (CMRA) may provide additional information, and in many cases may be diagnostic [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537235920\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of an anomalous coronary artery (usually the left anterior descending) originating from the pulmonary artery is made in a patient (often a young child) in whom it is suspected based on the findings described above with a diagnostic imaging modality (either CCTA or CMRA), which may vary among institutions. Coronary angiography, which was the gold standard, may be necessary in some cases and cardiac catheterization may provide additional hemodynamic information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;All anomalously arising coronary arteries from the pulmonary artery require surgical correction, which consists of reimplantation of the coronary artery to the aorta or tunneling of the coronary artery to the aorta (Takeuchi procedure) so that unimpeded normally saturated blood will reach the heart. Older therapies, such as ligation of the abnormally arising coronary artery, have been largely abandoned in favor of the establishment of a normal two coronary artery system [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/51\">",
"     51",
"    </a>",
"    ]. At this time, there are no percutaneous treatment options for abnormalities of coronary artery origin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     ABNORMALITIES IN THE CALIBER OF THE CORONARY ARTERIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in the caliber of the coronary arteries include narrowing due to stenosis or hypoplasia or enlargement, including ectasia or aneurysmal dilatation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Coronary artery narrowing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenosis of the coronary arteries can occur at the ostium or throughout the coronary artery. These lesions can be congenital or acquired. Acquired causes include drugs (eg, methysergide), prior surgical manipulation (as with reimplantation of the coronary arteries in the arterial switch operation or for anomalous origin of the coronary arteries), and other underlying diseases (eg, Kawasaki disease or familial hyperlipidemia). The pathophysiology is similar for all of the above causes with the common denominator of coronary blood flow insufficiency and myocardial ischemia, and its resultant signs and symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=see_link\">",
"     \"Pathophysiology and clinical presentation of ischemic chest pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stenoses of the coronary artery ostia result from a variety of disorders. It is important to be aware of the acquired disorders that must be distinguished from congenital disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/52\">",
"     52",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A congenital abnormality, such as an acute takeoff of the coronary artery from the sinus of Valsalva, which may become compressed with aortic root dilation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/2\">",
"       2",
"      </a>",
"      ], or formation of a nonatheromatous ridge",
"     </li>",
"     <li>",
"      Surgical manipulation (aortic valve surgery, coronary artery cannulation) near or directly involving the coronary arteries",
"     </li>",
"     <li>",
"      Syphilis",
"     </li>",
"     <li>",
"      Hyperlipoproteinemia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link\">",
"       \"Inherited disorders of LDL-cholesterol metabolism\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Takayasu arteritis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13624?source=see_link\">",
"       \"Clinical features and diagnosis of Takayasu arteritis\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Fibromuscular hyperplasia from methysergide therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Stenosis of the coronary artery itself also has many causes [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/53\">",
"     53",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital tunneling of the coronary arteries into the myocardium, known as myocardial bridges [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/54,55\">",
"       54,55",
"      </a>",
"      ] or arterial loops [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/56\">",
"       56",
"      </a>",
"      ], can cause localized narrowing of the coronary arteries. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/47/12023?source=see_link\">",
"       \"Myocardial bridging of the coronary arteries\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital hypoplasia due to long segment narrowing may involve one or both coronary arteries [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/57\">",
"       57",
"      </a>",
"      ]. There may be a remnant fibrous cord in the area usually occupied by a coronary artery, most often the left.",
"     </li>",
"     <li>",
"      In Williams syndrome with cardiac involvement, the location of the coronary arteries proximal to the area of supravalvular aortic stenosis may predispose to the development of intimal hyperplasia due to the associated hypertension [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/58\">",
"       58",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=see_link\">",
"       \"Clinical manifestations and diagnosis of bicuspid aortic valve\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5287?source=see_link\">",
"       \"Williams-Beuren syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acquired disorders include trauma; thrombosis or intimal hyperplasia of coronary artery aneurysms, as in Kawasaki disease (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30826?source=see_link\">",
"       \"Cardiovascular sequelae of Kawasaki disease\"",
"      </a>",
"      ); familial hyperlipidemia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=see_link\">",
"       \"Inherited disorders of LDL-cholesterol metabolism\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=see_link\">",
"       \"Early noncardiac complications of coronary artery bypass graft surgery\"",
"      </a>",
"      ); transplant-related coronary artery disease (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/25/44441?source=see_link\">",
"       \"Pathogenesis of and risk factors for cardiac allograft vasculopathy\"",
"      </a>",
"      ); and surgical coronary artery manipulation as a part of congenital heart surgery (eg, arterial switch procedure for transposition of the great arteries).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Screening and risk stratification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predisposition to or suspicion of coronary artery narrowing as noted above may be found in the history (risk factors). In individuals with risk factors (underlying diseases, prior surgeries, and those who are known to have coronary abnormalities) for coronary narrowing and inducible myocardial ischemia, long term surveillance is indicated to determine whether or not intervention is needed. Surveillance usually consists of imaging (noninvasive or invasive angiography), as well as an assessment for underlying ischemia (stress testing &ndash; exercise or pharmacologic, with noninvasive imaging &ndash; echocardiographic or nuclear). The frequency and type of surveillance varies among institutions and individual patients. Based on the surveillance findings, a risk for myocardial infarction and sudden death is estimated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment of coronary artery narrowing, whether congenital or acquired, is similar in children and adults [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/59\">",
"     59",
"    </a>",
"    ]. Depending upon the degree of narrowing and expected future risks of untreated narrowing, intervention may be indicated. Treatment can consist of one or more of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Risk factor reduction (eg, hyperlipidemia, hypertension, inflammation)",
"     </li>",
"     <li>",
"      Surgical intervention, including CABG or epicardial laser revascularization (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/51/9018?source=see_link\">",
"       \"Medical therapy versus revascularization in the management of stable angina pectoris\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28167?source=see_link\">",
"       \"Transmyocardial laser revascularization for management of refractory angina\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Percutaneous coronary intervention (PCI) with or without stent placement. Covered stents may be less prone to intimal hyperplasia in this setting [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/60\">",
"       60",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=see_link\">",
"       \"Drug-eluting intracoronary stents: General principles\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Coronary artery enlargement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Coronary artery enlargement can be either congenital or acquired: It can represent a physiologic response induced by increased demand in an hypertrophied ventricle or by increased flow due to coronary artery steal as seen with a coronary artery fistula (see",
"    <a class=\"local\" href=\"#H28\">",
"     'Coronary artery fistulae'",
"    </a>",
"    below) or anomalous origin of a coronary artery from the pulmonary artery (see",
"    <a class=\"local\" href=\"#H13\">",
"     'Variations of coronary artery origin from the pulmonary artery'",
"    </a>",
"    above). It can also be acquired in a disease involving the coronary arteries such as Kawasaki disease, in which there can be mild enlargement or irregularity (\"ectasia\") or aneurysmal dilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Coronary artery aneurysm",
"    </span>",
"    &nbsp;&mdash;&nbsp;A coronary artery aneurysm, or coronary artery ectasia, is defined as a segment of a coronary artery that dilates to a diameter exceeding the diameter of adjacent segments or the diameter of the largest coronary artery by 1.5 times [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/61\">",
"     61",
"    </a>",
"    ]. As seen with intracoronary ultrasound, a true aneurysm has an intact vessel wall; in contrast, a pseudoaneurysm, which on angiography may be difficult to distinguish from a true aneurysm, has loss of vessel wall integrity and damage to adventitia or perivascular tissue. The frequency with which angiography may give an incorrect diagnosis was addressed in a review of 77 older patients (mean age 61 years) who had an angiographic diagnosis of a native coronary artery aneurysm and underwent intracoronary ultrasound: 27 percent had a true aneurysm, 4 percent a pseudoaneurysm, 16 percent had complex atheromatous plaques, and 53 percent had normal arterial segments adjacent to a coronary stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/62\">",
"     62",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/27/34234?source=see_link\">",
"     \"Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among the congenital causes of coronary artery aneurysm are connective tissue diseases (eg, polycystic kidney disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/63\">",
"     63",
"    </a>",
"    ] and Ehlers-Danlos [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/64\">",
"     64",
"    </a>",
"    ] syndrome). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30233?source=see_link\">",
"     \"Extrarenal manifestations of autosomal dominant polycystic kidney disease\"",
"    </a>",
"    .) These disorders must be distinguished from a variety of acquired causes, especially in adults. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atheromatous disease.",
"     </li>",
"     <li>",
"      Arteritis in Kawasaki disease, which is the most frequent in children (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef56911 \" href=\"UTD.htm?35/51/36671\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef65317 \" href=\"UTD.htm?35/29/36318\">",
"       movie 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef53864 \" href=\"UTD.htm?18/43/19134\">",
"       movie 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_movie graphicRef76878 \" href=\"UTD.htm?16/54/17262\">",
"       movie 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/65\">",
"       65",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30826?source=see_link\">",
"       \"Cardiovascular sequelae of Kawasaki disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other causes of aneurysms due to arteritis include syphilis and Takayasu arteritis [",
"      <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/66\">",
"       66",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13624?source=see_link\">",
"       \"Clinical features and diagnosis of Takayasu arteritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Trauma or dissection.",
"     </li>",
"     <li>",
"      Angioplasty or atherectomy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=see_link\">",
"       \"Periprocedural complications of percutaneous coronary intervention\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27108?source=see_link\">",
"       \"Coronary complications of atheroablative devices\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sequelae of coronary artery aneurysms include rupture, which is rare, and thrombosis. The dilated segment has sluggish blood flow with a predisposition to thrombus formation, which can lead to symptoms of myocardial ischemia or to coronary artery emboli. In Kawasaki disease, the aneurysm may decrease in size over time due to intimal (medial) hyperplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Evaluation and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Resting and stress radionuclide myocardial perfusion imaging, using thallium or similar agents, to assess myocardial perfusion and function, and coronary angiography should be performed to determine the significance of the aneurysm or stenoses and the best therapeutic options [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/67\">",
"     67",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24970?source=see_link\">",
"     \"Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical intervention includes resection of the aneurysm and CABG [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/61,68\">",
"     61,68",
"    </a>",
"    ]. If stenosis is the main problem, PCI can be performed; the placement of a polymer coated stent may also be effective, although this has not yet been described in children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=see_link\">",
"     \"Drug-eluting intracoronary stents: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     CORONARY ARTERY FISTULAE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Communications between the coronary arteries and the cardiac chambers (coronary-cameral fistulae) or other vessels (coronary artery arteriovenous malformations) are often due to deviations from normal embryological development (see",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above). They may also be acquired from trauma (stab, gunshot or projectile injuries), or from invasive cardiac procedures such as pacemaker implantation, endomyocardial biopsy, or coronary angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/70\">",
"     70",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The resultant physiologic derangement depends upon the site of origin and termination of the abnormal connection and the size of the connection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/71\">",
"     71",
"    </a>",
"    ]. The major sites of origin are the right coronary artery (55 percent), the left coronary artery system (35 percent), and both coronary arteries (5 percent). The major termination sites with right and left coronary artery origins are the right ventricle (40 percent) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56611 \" href=\"UTD.htm?23/49/24337\">",
"     image 3",
"    </a>",
"    ), right atrium (26 percent) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71551 \" href=\"UTD.htm?6/44/6849\">",
"     image 4",
"    </a>",
"    ), and pulmonary arteries (17 percent). The fistulae less frequently drain into the superior vena cava or coronary sinus, and least often to the left atrium or left ventricle.",
"   </p>",
"   <p>",
"    The outcome with these connections depends upon the termination site:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      There is a left-to-right shunt if termination is to the systemic venous side",
"     </li>",
"     <li>",
"      There is left-sided volume overloading if the termination is in the left-sided cardiac structures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The volume of the shunt varies with the size of the fistula and differences between the systemic resistance and the resistance in the terminating",
"    <span class=\"nowrap\">",
"     vessel/chamber;",
"    </span>",
"    flow moves from the coronary arteries to the lower pressure chambers or vessels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Symptoms and complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most coronary artery fistulae are small, myocardial blood flow is not compromised, and the patient is asymptomatic. However, there may be coronary artery steal, with resultant ischemia of the segment of myocardium perfused by the coronary artery distal to the fistula; the coronary artery proximal to the fistula enlarges in a compensatory fashion.",
"   </p>",
"   <p>",
"    If untreated, hemodynamically significant fistulae may result in clinical symptoms or sequelae in approximately 19 percent of patients under the age of 20 and 63 percent of those over the age of 20 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/72\">",
"     72",
"    </a>",
"    ]. Symptoms and sequelae include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic myocardial ischemia and angina",
"     </li>",
"     <li>",
"      Heart failure and a cardiomyopathy",
"     </li>",
"     <li>",
"      Myocardial infarction",
"     </li>",
"     <li>",
"      Pulmonary hypertension",
"     </li>",
"     <li>",
"      Endocarditis",
"     </li>",
"     <li>",
"      Rhythm abnormalities",
"     </li>",
"     <li>",
"      Thrombosis of the fistula or an associated aneurysm",
"     </li>",
"     <li>",
"      Rupture of the fistula, which is rare",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Spontaneous closure has been reported in children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/73\">",
"     73",
"    </a>",
"    ], and less frequently in adults. Spontaneous closure may be a more common occurrence in biopsy-related coronary-cameral fistulae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many patients with a coronary artery fistula are identified and referred because of the associated murmur, which is loud, superficial, and continuous at the lower or midsternal border, depending upon the site of drainage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link&amp;anchor=H52#H52\">",
"     \"Auscultation of cardiac murmurs\", section on 'Continuous murmurs'",
"    </a>",
"    .) The chest x-ray and electrocardiogram are normal if the shunt through the fistula is small, but may show evidence of chamber enlargement or ischemia with a larger shunt and coronary artery steal.",
"   </p>",
"   <p>",
"    Significantly enlarged coronary arteries can be detected by two-dimensional echocardiography. The actual diagnosis of a coronary artery fistula can often be made with transthoracic two dimensional and color Doppler echocardiography in children. However, in adults, two dimensional transesophageal echocardiography may be more sensitive for detection of the entrance and termination site of the shunt, which is characterized by a continuous turbulent systolic and diastolic flow pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/74\">",
"     74",
"    </a>",
"    ]. In one report of 21 coronary artery fistulas detected by the transesophageal approach in 17 adults and four adolescents, transthoracic echocardiography was suggestive of a fistula in only 6 of 18 patients in whom the test was performed.",
"   </p>",
"   <p>",
"    Coronary fistulae have also been detected non-invasively using 64-slice multi-detector computed tomography [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The size and anatomical features of the fistula can be reliably established during coronary angiography or with retrograde thoracic and aortic root aortography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemodynamically insignificant fistulae, which are clinically silent and not associated with other abnormal findings, may not require further treatment. Large, hemodynamically significant fistulae should be closed by ligation. Smaller coronary fistulae tend to get larger with age. As a result, it is usually recommended that elective closure be performed early in patients who have symptoms or who are asymptomatic but have a continuous murmur or a systolic murmur with an early diastolic component [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical methods of closure are associated with low mortality and morbidity; long-term outcome is excellent and most patients remain asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Despite the good results with surgery, closure during cardiac catheterization has become the method of choice. Various percutaneous catheter techniques have been employed, including Gianturco coils (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef56611 \" href=\"UTD.htm?23/49/24337\">",
"     image 3",
"    </a>",
"    ), interlocking detachable coils, detachable balloons, polyvinyl alcohol foam, double umbrellas, the Amplatzer duct occluder (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef71551 \" href=\"UTD.htm?6/44/6849\">",
"     image 4",
"    </a>",
"    ), and the Amplatzer vascular plug [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/70,78-84\">",
"     70,78-84",
"    </a>",
"    ]. Risks of fistula closure with these devices include myocardial infarction and migration of coils or discs to extracoronary vascular structures or within the coronary artery branches [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The potential efficacy and safety of transcatheter closure was illustrated in a review of 35 procedures (coil in 28, umbrella device in six, and vascular occlusion device in one) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/78\">",
"     78",
"    </a>",
"    ]. Postdeployment, there was complete occlusion in 19, trace flow in 11, and small residual flow in five. At a median follow-up of two years in 27 patients, there was no flow in 22 and small residual flow in five. Early complications include transient ST and T changes in five, transient arrhythmia in five, and single cases of fistula dissection and coil embolization. Device placement was not attempted in patients with multiple fistula drainage sites.",
"   </p>",
"   <p>",
"    The risk of endocarditis is unclear, but endocarditis prophylaxis is not indicated [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/83\">",
"     83",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=see_link\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Persistent sinusoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct communication from the cardiac chambers without a discrete vessel between the coronary artery and termination site result from sinusoids that persist during development of the heart (see",
"    <a class=\"local\" href=\"#H1\">",
"     'Introduction'",
"    </a>",
"    above). These are usually seen with congenital heart defects such as pulmonary atresia or aortic atresia with an intact ventricular septum. The coronary artery perfusion in these patients may be dependent on flow from the ventricles to coronary arteries via the sinusoids. Thus, ventricular pressure must be maintained; the sinusoids should not be occluded nor should the ventricular pressure be lowered with valvuloplasty in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of persistent sinusoids can be made with color Doppler echocardiography to show abnormal flow from a ventricular cavity to the epicardium and to the coronary arteries if the shunt is large [",
"    <a class=\"abstract\" href=\"UTD.htm?13/56/14218/abstract/86\">",
"     86",
"    </a>",
"    ]. However, the diagnosis is more frequently made during angiography, which is part of the usual diagnostic evaluation of patients in whom sinusoids are likely to exist (eg, pulmonary atresia with intact septum).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H169945980\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital anomalies of the coronary circulation include variations in origin, abnormalities in caliber, and coronary artery fistulae. The following are important points made in this topic:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of abnormal aortic origin of the coronary arteries is low, with reported values of approximately 0.64 percent of births and 0.17 percent in asymptomatic children and adolescents who were referred for and underwent echocardiography. The most common anomaly is the left circumflex from the right sinus of Valsalva, followed by a single coronary artery from the left sinus of Valsalva, both coronary arteries from the right sinus of Valsalva, and the left anterior descending from the right sinus of Valsalva. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Variations of coronary artery origin from the aorta'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Separate origins of the right coronary artery and its conal branch occur in 50 percent of the population and separate origins of the left circumflex coronary artery and left anterior descending artery in 1 percent. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Variations of coronary artery origin from the aorta'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Variations in origin of the coronary arteries from the aorta are commonly seen with congenital heart diseases such as tetralogy of Fallot, transposition of the great arteries, double outlet right ventricle, univentricular hearts, and truncus arteriosus. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Association with other congenital heart diseases'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Aortic origin of the left coronary artery from the right sinus of Valsalva may result in ischemia and sudden death. A single coronary artery originating from the right sinus of Valsalva may result in ischemia from a similar mechanism. The clinical presentation of a patient with these abnormalities may be anginal chest pain, or syncope, especially with exercise. Unfortunately, the first clinical symptom may be sudden death, particularly in young athletes and military recruits. However, management of asymptomatic individuals is still under investigation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Variations of coronary artery origin from the aorta'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      While coronary angiography is the &lsquo;gold standard&rsquo;, computed tomograph angiography and cardiac magnetic resonance imaging is becoming more frequently used.",
"      <br/>",
"      <br/>",
"      Surgical intervention is indicated for coronary artery abnormalities associated with serious ventricular tachyarrhythmias or myocardial ischemia.",
"     </li>",
"     <li>",
"      An anomalous origin of one or more coronary arteries from the pulmonary artery is usually an isolated abnormality, occurring in 0.4 percent of patients with congenital cardiac abnormalities (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef62373 \" href=\"UTD.htm?41/45/42706\">",
"       image 1",
"      </a>",
"      ). Such lesions are hemodynamically significant and produce myocardial ischemia that may be progressive and lead to ischemic cardiomyopathy. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Variations of coronary artery origin from the pulmonary artery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Abnormalities in the caliber of the coronary arteries include narrowing due to stenosis or hypoplasia or enlargement, including ectasia or aneurysmal dilatation. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Abnormalities in the caliber of the coronary arteries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Communications between the coronary arteries and the cardiac chambers (coronary-cameral fistulae) or other vessels (coronary artery arteriovenous malformations) are often due to deviations from normal embryological development. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.) They may also be acquired from trauma (stab, gunshot or projectile injuries), or from invasive cardiac procedures such as pacemaker implantation, endomyocardial biopsy, or coronary angiography. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Coronary artery fistulae'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Neufeld HN, Schneeweiss A. Coronary Artery Disease in Infants and Children, Lea and Febiger, Philadelphia 1983.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/2\">",
"      BURCK HC. [HIGH AND FUNNEL-LIKE ORIGIN OF THE CORONARY ARTERIES]. Beitr Pathol Anat 1963; 128:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/3\">",
"      Cheitlin MD, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary origin from the anterior sinus of Valsalva, A not-so-minor congenital anomaly. Circulation 1974; 50:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/4\">",
"      Barth CW 3rd, Roberts WC. Left main coronary artery originating from the right sinus of Valsalva and coursing between the aorta and pulmonary trunk. J Am Coll Cardiol 1986; 7:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/5\">",
"      Lorenz EC, Mookadam F, Mookadam M, et al. A systematic overview of anomalous coronary anatomy and an examination of the association with sudden cardiac death. Rev Cardiovasc Med 2006; 7:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/6\">",
"      Kaushal S, Backer CL, Popescu AR, et al. Intramural coronary length correlates with symptoms in patients with anomalous aortic origin of the coronary artery. Ann Thorac Surg 2011; 92:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/7\">",
"      Taylor AJ, Rogan KM, Virmani R. Sudden cardiac death associated with isolated congenital coronary artery anomalies. J Am Coll Cardiol 1992; 20:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/8\">",
"      Kimbiris D, Iskandrian AS, Segal BL, Bemis CE. Anomalous aortic origin of coronary arteries. Circulation 1978; 58:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/9\">",
"      Davis JA, Cecchin F, Jones TK, Portman MA. Major coronary artery anomalies in a pediatric population: incidence and clinical importance. J Am Coll Cardiol 2001; 37:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/10\">",
"      Brothers J, Gaynor JW, Paridon S, et al. Anomalous aortic origin of a coronary artery with an interarterial course: understanding current management strategies in children and young adults. Pediatr Cardiol 2009; 30:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/11\">",
"      Yamanaka O, Hobbs RE. Coronary artery anomalies in 126,595 patients undergoing coronary arteriography. Cathet Cardiovasc Diagn 1990; 21:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/12\">",
"      McCaffrey FM, Braden DS, Strong WB. Sudden cardiac death in young athletes. A review. Am J Dis Child 1991; 145:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/13\">",
"      Maron BJ, Carney KP, Lever HM, et al. Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 41:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/14\">",
"      Eckart RE, Scoville SL, Campbell CL, et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 2004; 141:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/15\">",
"      Gersony WM. Management of anomalous coronary artery from the contralateral coronary sinus. J Am Coll Cardiol 2007; 50:2083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/16\">",
"      Chaitman BR, Lesp&eacute;rance J, Saltiel J, Bourassa MG. Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries. Circulation 1976; 53:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/17\">",
"      Frommelt PC, Frommelt MA, Tweddell JS, Jaquiss RD. Prospective echocardiographic diagnosis and surgical repair of anomalous origin of a coronary artery from the opposite sinus with an interarterial course. J Am Coll Cardiol 2003; 42:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/18\">",
"      Graham TP Jr, Driscoll DJ, Gersony WM, et al. Task Force 2: congenital heart disease. J Am Coll Cardiol 2005; 45:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/19\">",
"      McConnell MV, Ganz P, Selwyn AP, et al. Identification of anomalous coronary arteries and their anatomic course by magnetic resonance coronary angiography. Circulation 1995; 92:3158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/20\">",
"      Post JC, van Rossum AC, Bronzwaer JG, et al. Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 1995; 92:3163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/21\">",
"      Taylor AM, Thorne SA, Rubens MB, et al. Coronary artery imaging in grown up congenital heart disease: complementary role of magnetic resonance and x-ray coronary angiography. Circulation 2000; 101:1670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/22\">",
"      Bunce NH, Lorenz CH, Keegan J, et al. Coronary artery anomalies: assessment with free-breathing three-dimensional coronary MR angiography. Radiology 2003; 227:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/23\">",
"      Datta J, White CS, Gilkeson RC, et al. Anomalous coronary arteries in adults: depiction at multi-detector row CT angiography. Radiology 2005; 235:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/24\">",
"      Ropers D, Moshage W, Daniel WG, et al. Visualization of coronary artery anomalies and their anatomic course by contrast-enhanced electron beam tomography and three-dimensional reconstruction. Am J Cardiol 2001; 87:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/25\">",
"      Deibler AR, Kuzo RS, V&ouml;hringer M, et al. Imaging of congenital coronary anomalies with multislice computed tomography. Mayo Clin Proc 2004; 79:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/26\">",
"      Brothers JA, McBride MG, Seliem MA, et al. Evaluation of myocardial ischemia after surgical repair of anomalous aortic origin of a coronary artery in a series of pediatric patients. J Am Coll Cardiol 2007; 50:2078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/27\">",
"      Mainwaring RD, Reddy VM, Reinhartz O, et al. Anomalous aortic origin of a coronary artery: medium-term results after surgical repair in 50 patients. Ann Thorac Surg 2011; 92:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/28\">",
"      Romp RL, Herlong JR, Landolfo CK, et al. Outcome of unroofing procedure for repair of anomalous aortic origin of left or right coronary artery. Ann Thorac Surg 2003; 76:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/29\">",
"      Lopez L, Mercer-Rosa L, Zahn EM, et al. The \"hinge-twist\" technique for anomalous origin of the left coronary artery. Ann Thorac Surg 2006; 82:e19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/30\">",
"      Gulati R, Reddy VM, Culbertson C, et al. Surgical management of coronary artery arising from the wrong coronary sinus, using standard and novel approaches. J Thorac Cardiovasc Surg 2007; 134:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/31\">",
"      Doorey AJ, Pasquale MJ, Lally JF, et al. Six-month success of intracoronary stenting for anomalous coronary arteries associated with myocardial ischemia. Am J Cardiol 2000; 86:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/32\">",
"      MENG CC, ECKNER FA, LEV M. CORONARY ARTERY DISTRIBUTION IN TETRALOGY OF FALLOT. Arch Surg 1965; 90:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/33\">",
"      Dabizzi RP, Caprioli G, Aiazzi L, et al. Distribution and anomalies of coronary arteries in tetralogy of fallot. Circulation 1980; 61:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/34\">",
"      Wernovsky G, Sanders SP. Coronary artery anatomy and transposition of the great arteries. Coron Artery Dis 1993; 4:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/35\">",
"      Shaher RM, Puddu GC. Coronary arterial anatomy in complete transposition of the great vessels. Am J Cardiol 1966; 17:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/36\">",
"      Elliott LP, Amplatz K, Edwards JE. Coronary arterial patterns in transposition complexes. Anatomic and angiocardiographic studies. Am J Cardiol 1966; 17:362.",
"     </a>",
"    </li>",
"    <li>",
"     Kirklin JW, Barratt-Boyesn BG. Congenitally corrected transposition of the great arteries. In: Cardiac Surgery, Kirklin JW, Barratt-Boyes BG (Eds), John Wiley &amp; Sons, New York 1993. p.1511.",
"    </li>",
"    <li>",
"     Vlodaver Z, Neufeld HN, Edwards JE. Coronary Artery Variations in the Normal Heart and in Congenital Heart Disease, Academic Press, San Diego 1975.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/39\">",
"      Anderson KR, McGoon DC, Lie JT. Surgical significance of the coronary arterial anatomy in truncus arteriosus communis. Am J Cardiol 1978; 41:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/40\">",
"      Shrivastava S, Edwards JE. Coronary arterial origin in persistent truncus arteriosus. Circulation 1977; 55:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/41\">",
"      EDWARDS JE. THE DIRECTION OF BLOOD FLOW IN CORONARY ARTERIES ARISING FROM THE PULMONARY TRUNK. Circulation 1964; 29:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/42\">",
"      Wright NL, Baue AE, Baum S, et al. Coronary artery steal due to an anomalous left coronary artery originating from the pulmonary artery. J Thorac Cardiovasc Surg 1970; 59:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/43\">",
"      Bland, EF, White, PD, Garland, J. Congenital anomalies of the coronary arteries: report of an unusual case associated with cardiac hypertrophy. Am Heart J 1933; 8:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/44\">",
"      Wesselhoeft H, Fawcett JS, Johnson AL. Anomalous origin of the left coronary artery from the pulmonary trunk. Its clinical spectrum, pathology, and pathophysiology, based on a review of 140 cases with seven further cases. Circulation 1968; 38:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/45\">",
"      LIEBMAN J, HELLERSTEIN HK, ANKENEY JL, TUCKER A. THE PROBLEM OF THE ANOMALOUS LEFT CORONARY ARTERY ARISING FROM THE PULMONARY ARTERY IN OLDER CHILDREN. REPORT OF THREE CASES. N Engl J Med 1963; 269:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/46\">",
"      Roberts WC, Robinowitz M. Anomalous origin of the left anterior descending coronary artery from the pulmonary trunk with origin of the right and left circumflex coronary arteries from the aorta. Am J Cardiol 1984; 54:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/47\">",
"      Roberts WC. Major anomalies of coronary arterial origin seen in adulthood. Am Heart J 1986; 111:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/48\">",
"      Lerberg DB, Ogden JA, Zuberbuhler JR, Bahnson HT. Anomalous origin of the right coronary artery from the pulmonary artery. Ann Thorac Surg 1979; 27:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/49\">",
"      Hoffman JI. Electrocardiogram of anomalous left coronary artery from the pulmonary artery in infants. Pediatr Cardiol 2013; 34:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/50\">",
"      Srinivasan KG, Gaikwad A, Kannan BR, et al. Congenital coronary artery anomalies: diagnosis with 64 slice multidetector row computed tomography coronary angiography: a single-centre study. J Med Imaging Radiat Oncol 2008; 52:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/51\">",
"      Backer CL, Stout MJ, Zales VR, et al. Anomalous origin of the left coronary artery. A twenty-year review of surgical management. J Thorac Cardiovasc Surg 1992; 103:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/52\">",
"      Waller BF, Orr CM, Slack JD, et al. Anatomy, histology, and pathology of coronary arteries: a review relevant to new interventional and imaging techniques--Part I. Clin Cardiol 1992; 15:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/53\">",
"      Waller BF, Fry ET, Hermiller JB, et al. Nonatherosclerotic causes of coronary artery narrowing--Part II. Clin Cardiol 1996; 19:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/54\">",
"      Angelini P, Trivellato M, Donis J, Leachman RD. Myocardial bridges: a review. Prog Cardiovasc Dis 1983; 26:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/55\">",
"      Visscher DW, Miles BL, Waller BF. Tunneled (\"bridged\") left anterior descending coronary artery in a newborn without clinical or morphologic evidence of myocardial ischemia. Cathet Cardiovasc Diagn 1983; 9:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/56\">",
"      Bashour TT, Mansour NN, Lee D. Multiple coronary arterial loops as a cause of myocardial ischemia. Am Heart J 1993; 126:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/57\">",
"      Roberts WC, Glick BN. Congenital hypoplasia of both right and left circumflex coronary arteries. Am J Cardiol 1992; 70:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/58\">",
"      Terhune PE, Buchino JJ, Rees AH. Myocardial infarction associated with supravalvular aortic stenosis. J Pediatr 1985; 106:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/59\">",
"      Moore JW, Buchbinder M. Successful coronary stenting in a 4-year-old child. Cathet Cardiovasc Diagn 1998; 44:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/60\">",
"      Stefanadis C, Toutouzas K, Tsiamis E, et al. Stents covered by an autologous arterial graft in porcine coronary arteries: feasibility, vascular injury and effect on neointimal hyperplasia. Cardiovasc Res 1999; 41:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/61\">",
"      Syed M, Lesch M. Coronary artery aneurysm: a review. Prog Cardiovasc Dis 1997; 40:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/62\">",
"      Maehara A, Mintz GS, Ahmed JM, et al. An intravascular ultrasound classification of angiographic coronary artery aneurysms. Am J Cardiol 2001; 88:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/63\">",
"      Hadimeri H, Lamm C, Nyberg G. Coronary aneurysms in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1998; 9:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/64\">",
"      Eriksen UH, Aunsholt NA, Nielsen TT. Enormous right coronary arterial aneurysm in a patient with type IV Ehlers-Danlos syndrome. Int J Cardiol 1992; 35:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/65\">",
"      Newburger JW, Burns JC. Kawasaki disease. Vasc Med 1999; 4:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/66\">",
"      Suzuki H, Daida H, Tanaka M, et al. Giant aneurysm of the left main coronary artery in Takayasu aortitis. Heart 1999; 81:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/67\">",
"      Hijazi ZM, Udelson JE, Snapper H, et al. Physiologic significance of chronic coronary aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 1994; 24:1633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/68\">",
"      Glickel SZ, Maggs PR, Ellis FH Jr. Coronary artery aneurysm. Ann Thorac Surg 1978; 25:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/69\">",
"      Heuser RR, Woodfield S, Lopez A. Obliteration of a coronary artery aneurysm with a PTFE-covered stent: endoluminal graft for coronary disease revisited. Catheter Cardiovasc Interv 1999; 46:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/70\">",
"      Spaedy, TJ, Wilensky, RL. Coronary artery fistulas: clinical implications. ACC Current Journal Review 1994; 3:24.",
"     </a>",
"    </li>",
"    <li>",
"     Hoffman JI. Congenital anomalies of the coronary vessels and the aortic root. In: Heart disease in infants, children and adolescents, 5th ed, Emmanoulides GC, Riemenschneider TA, Allen HD, Gutgesell HP (Eds), Williams and Wilkins, Baltimore 1995. p.780.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/72\">",
"      Liberthson RR, Sagar K, Berkoben JP, et al. Congenital coronary arteriovenous fistula. Report of 13 patients, review of the literature and delineation of management. Circulation 1979; 59:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/73\">",
"      Cotton JL. Diagnosis of a left coronary artery to right ventricular fistula with progression to spontaneous closure. J Am Soc Echocardiogr 2000; 13:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/74\">",
"      Vitarelli A, De Curtis G, Conde Y, et al. Assessment of congenital coronary artery fistulas by transesophageal color Doppler echocardiography. Am J Med 2002; 113:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/75\">",
"      Natarajan A, Khokhar AA, Kirk P, et al. Coronary-pulmonary artery fistula: value of 64-MDCT imaging. QJM 2013; 106:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/76\">",
"      Urrutia-S CO, Falaschi G, Ott DA, Cooley DA. Surgical management of 56 patients with congenital coronary artery fistulas. Ann Thorac Surg 1983; 35:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/77\">",
"      Cheung DL, Au WK, Cheung HH, et al. Coronary artery fistulas: long-term results of surgical correction. Ann Thorac Surg 2001; 71:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/78\">",
"      Armsby LR, Keane JF, Sherwood MC, et al. Management of coronary artery fistulae. Patient selection and results of transcatheter closure. J Am Coll Cardiol 2002; 39:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/79\">",
"      Reidy JF, Anjos RT, Qureshi SA, et al. Transcatheter embolization in the treatment of coronary artery fistulas. J Am Coll Cardiol 1991; 18:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/80\">",
"      Perry SB, Rome J, Keane JF, et al. Transcatheter closure of coronary artery fistulas. J Am Coll Cardiol 1992; 20:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/81\">",
"      Ogoh Y, Akagi T, Abe T, et al. Successful embolization of coronary arteriovenous fistula using an interlocking detachable coil. Pediatr Cardiol 1997; 18:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/82\">",
"      Hakim F, Madani A, Goussous Y, et al. Transcatheter closure of a large coronary arteriovenous fistula using the new Amplatzer Duct Occluder. Cathet Cardiovasc Diagn 1998; 45:155.",
"     </a>",
"    </li>",
"    <li>",
"     Wilson W, Taubert KA, Gewitz M, et al. Prevention of Infective Endocarditis. Guidelines From the American Heart Association. A Guideline From the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 115 published online April 19, 2007. www.circ.ahajournals.org/cgi/reprint/CIRCULATIONAHA.106.183095v1 (Accessed on May 04, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/84\">",
"      Hill SL, Hijazi ZM, Hellenbrand WE, Cheatham JP. Evaluation of the AMPLATZER vascular plug for embolization of peripheral vascular malformations associated with congenital heart disease. Catheter Cardiovasc Interv 2006; 67:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/85\">",
"      Kharouf R, Cao QL, Hijazi ZM. Transcatheter closure of coronary artery fistula complicated by myocardial infarction. J Invasive Cardiol 2007; 19:E146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/56/14218/abstract/86\">",
"      Garcia JA, Zellers TM, Weinstein EM, Mahony L. Usefulness of Doppler echocardiography in diagnosing right ventricular coronary arterial communications in patients with pulmonary atresia and intact ventricular septum and comparison with angiography. Am J Cardiol 1998; 81:103.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1536 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-197.136.42.3-743D36F484-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14218=[""].join("\n");
var outline_f13_56_14218=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H169945980\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      VARIATIONS OF CORONARY ARTERY ORIGIN FROM THE AORTA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Incidence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Association with other congenital heart diseases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Transposition of the great arteries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Truncus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other congenital heart defects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      VARIATIONS OF CORONARY ARTERY ORIGIN FROM THE PULMONARY ARTERY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Clinical presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Chest x-ray and electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Noninvasive imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H537235920\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      ABNORMALITIES IN THE CALIBER OF THE CORONARY ARTERIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Coronary artery narrowing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Screening and risk stratification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Coronary artery enlargement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Coronary artery aneurysm",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Evaluation and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      CORONARY ARTERY FISTULAE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Symptoms and complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Persistent sinusoids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H169945980\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1536\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1536|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?41/45/42706\" title=\"diagnostic image 1\">",
"      Anomalous left circumflex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?35/51/36671\" title=\"diagnostic image 2\">",
"      Kawasaski multiple CA aneurysms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/49/24337\" title=\"diagnostic image 3\">",
"      Coronary artery fistula coil",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/44/6849\" title=\"diagnostic image 4\">",
"      Coronary artery fistula occluder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1536|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?35/29/36318\" title=\"movie 1\">",
"      Ascending aorta in Kawasaki disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?18/43/19134\" title=\"movie 2\">",
"      Left coronary artery in Kawasaki disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?16/54/17262\" title=\"movie 3\">",
"      Right coronary artery in Kawasaki disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/6/30826?source=related_link\">",
"      Cardiovascular sequelae of Kawasaki disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13624?source=related_link\">",
"      Clinical features and diagnosis of Takayasu arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/1/6169?source=related_link\">",
"      Clinical manifestations and diagnosis of bicuspid aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=related_link\">",
"      Clinical manifestations and diagnosis of patent ductus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/1/8216?source=related_link\">",
"      Coronary collateral circulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/30/27108?source=related_link\">",
"      Coronary complications of atheroablative devices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/43/43702?source=related_link\">",
"      Drug-eluting intracoronary stents: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/25/35226?source=related_link\">",
"      Early noncardiac complications of coronary artery bypass graft surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/24/11658?source=related_link\">",
"      Electrocardiogram in the diagnosis of myocardial ischemia and infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/30/19945?source=related_link\">",
"      Evaluation of the patient with suspected heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/24/24970?source=related_link\">",
"      Exercise radionuclide myocardial perfusion imaging in the diagnosis and prognosis of coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/33/30233?source=related_link\">",
"      Extrarenal manifestations of autosomal dominant polycystic kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/25/37274?source=related_link\">",
"      Inherited disorders of LDL-cholesterol metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/27/34234?source=related_link\">",
"      Intravascular ultrasound, optical coherence tomography, and angioscopy of coronary circulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/51/9018?source=related_link\">",
"      Medical therapy versus revascularization in the management of stable angina pectoris",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/47/12023?source=related_link\">",
"      Myocardial bridging of the coronary arteries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/26/20906?source=related_link\">",
"      Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28794?source=related_link\">",
"      Overview of the management of tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/25/44441?source=related_link\">",
"      Pathogenesis of and risk factors for cardiac allograft vasculopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=related_link\">",
"      Pathophysiology and clinical presentation of ischemic chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38666?source=related_link\">",
"      Periprocedural complications of percutaneous coronary intervention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/36/13898?source=related_link\">",
"      Risk of sudden cardiac death in athletes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/32/28167?source=related_link\">",
"      Transmyocardial laser revascularization for management of refractory angina",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/10/5287?source=related_link\">",
"      Williams-Beuren syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_56_14219="WFNS SAH grading scale";
var content_f13_56_14219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F65468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F65468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    World Federation of Neurological Surgeons subarachnoid hemorrhage grading scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        GCS score",
"       </td>",
"       <td class=\"subtitle1\">",
"        Motor deficit",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        15",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2",
"       </td>",
"       <td>",
"        13 to 14",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        13 to 14",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4",
"       </td>",
"       <td>",
"        7 to 12",
"       </td>",
"       <td>",
"        Present or absent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5",
"       </td>",
"       <td>",
"        3 to 6",
"       </td>",
"       <td>",
"        Present or absent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GCS: Glasgow Coma Scale.",
"    </div>",
"    <div class=\"reference\">",
"     Based upon data from: Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988; 68:985.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14219=[""].join("\n");
var outline_f13_56_14219=null;
var title_f13_56_14220="Het proteins and serum sickness";
var content_f13_56_14220=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F51122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F51122&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Heterologous proteins causing serum sickness",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Microbial antitoxins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equine anti-diphtheria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equine or ovine anti-rabies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equine anti-botulinin toxin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Venom anti-toxins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equine, rabbit, ovine anti-snake venom (crotalidae (pit vipers, rattlesnakes) antivenin, micrurus (coral snake) antivenin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equine anti-spider venom (lactrodectus) antivenin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Immunomodulators",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Equine or rabbit antithymocyte globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Murine antiCD3 (OKT3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rituximab (murine/human chimeric anti-CD20)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Infliximab (murine/human chimeric anti-TNF alpha)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Alemtuzumab (humanized anti-CD52, Campath)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Omalizumab",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Natalizumab",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Immunizations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rabies antigens (human diploid cell rabies vaccine)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pneumococcal vaccine (?)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hemophilus B vaccine (?)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tissue culture protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bovine serum albumin (tissue culture media)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Therapeutic fibrinolytic proteins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Streptokinase",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Insect protein",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mosquito salivary proteins (?)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insect stings",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     (?): case reports; causality&nbsp;is unclear.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14220=[""].join("\n");
var outline_f13_56_14220=null;
var title_f13_56_14221="Visceral leishmaniasis species";
var content_f13_56_14221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58861&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of visceral leishmaniasis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Subgenus",
"       </td>",
"       <td class=\"subtitle1\">",
"        Complex",
"       </td>",
"       <td class=\"subtitle1\">",
"        Species",
"       </td>",
"       <td class=\"subtitle1\">",
"        Main geographic locations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Main clinical manifestation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\" rowspan=\"1\">",
"        Old World",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"5\">",
"        Leishmania",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        L. donovani",
"       </td>",
"       <td>",
"        L. donovani",
"       </td>",
"       <td>",
"        India, sub-Saharan Africa, China, Pakistan",
"       </td>",
"       <td>",
"        Visceral leishmaniasis",
"       </td>",
"       <td>",
"        Post kala-azar dermal leismaniasis (PKDL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. infantum*",
"       </td>",
"       <td>",
"        Mediterranean, Middle East, north and sub-Saharan",
"Africa, Balkans, China",
"       </td>",
"       <td>",
"        Visceral leishmaniasis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. major",
"       </td>",
"       <td>",
"        L. major",
"       </td>",
"       <td>",
"        Middle East, Africa, India, China",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis (\"wet ulcer\")",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. tropica",
"       </td>",
"       <td>",
"        L. tropica",
"       </td>",
"       <td>",
"        Middle East, India, southern Europe, western Asia",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis (\"dry ulcer\")",
"       </td>",
"       <td>",
"        Leishmaniasis recidivans (LR) and viscerotropic",
"leishmaniasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. aethiopica",
"       </td>",
"       <td>",
"        L. aethiopica",
"       </td>",
"       <td>",
"        Ethiopia, Kenya, Yemen",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis",
"       </td>",
"       <td>",
"        Diffuse cutaneous leishmaniasis (DCL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\" rowspan=\"1\">",
"        New World",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"4\">",
"        Leishmania",
"       </td>",
"       <td>",
"        L. donovani",
"       </td>",
"       <td>",
"        L. chagasi*",
"       </td>",
"       <td>",
"        Latin America",
"       </td>",
"       <td>",
"        Visceral leishmaniasis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        L. mexicana",
"       </td>",
"       <td>",
"        L. venezuelensis",
"       </td>",
"       <td>",
"        Venezuela",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. mexicana",
"       </td>",
"       <td>",
"        Mexico, Central America, Texas, Oklahoma",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis",
"       </td>",
"       <td>",
"        Diffuse cutaneous leishmaniasis (DCL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. amazonensis",
"       </td>",
"       <td>",
"        Amazon basin, Brazil",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis",
"       </td>",
"       <td>",
"        Diffuse cutaneous leishmaniasis (DCL). Has also been",
"associated with viceral leishmaniasis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"4\">",
"        Viannia",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        L. braziliensis",
"       </td>",
"       <td>",
"        L. braziliensis",
"       </td>",
"       <td>",
"        Latin America",
"       </td>",
"       <td>",
"        Cutaneous and mucocutaneous leishmaniasis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. peruviana",
"       </td>",
"       <td>",
"        Peru and Argentina (highlands)",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        L. guyanensis",
"       </td>",
"       <td>",
"        L. guyanensis",
"       </td>",
"       <td>",
"        Northern Amazon basin, Guyanas",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        L. panamensis",
"       </td>",
"       <td>",
"        Panama, Costa Rica, Columbia",
"       </td>",
"       <td>",
"        Cutaneous leishmaniasis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Organisms belonging to the subgenus Leishmania develop in the sandfly midgut, whereas organisms belonging to the subspecies Viannia develop in the hindgut.",
"     <br>",
"      * L. infantum and L. chagasi are now thought to be the same organism.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14221=[""].join("\n");
var outline_f13_56_14221=null;
var title_f13_56_14222="Toxicity of gold compounds";
var content_f13_56_14222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F61137&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F61137&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Toxicity profile with gold compounds",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Adverse effects",
"       </td>",
"       <td class=\"subtitle1\">",
"        Aurothiomalate",
"       </td>",
"       <td class=\"subtitle1\">",
"        Aurothioglucose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Auranofin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Postinjection reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vasomotor (nitritoid)",
"       </td>",
"       <td>",
"        Uncommon*",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anaphylaxis/syncope",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myalgias/arthralgias",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Mucocutaneous effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Dermatitis/stomatitis",
"       </td>",
"       <td>",
"        Common&bull;",
"       </td>",
"       <td>",
"        Less common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pruritus",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Less common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alopecia",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Urticaria",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trophic nails",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chrysiasis/pigmentation",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Photosensitivity",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Kidney",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Proteinuria",
"       </td>",
"       <td>",
"        Common&Delta;",
"       </td>",
"       <td>",
"        Less common",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hematuria",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"       <td>",
"        Less common",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nephrotic syndrome",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Renal insufficiency",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Blood",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Eosinophilia",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Thrombocytopenia",
"       </td>",
"       <td>",
"        Rare&Delta;",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Granulocytopenia",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymphocytopenia",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hypogammaglobulinemia",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aplastic anemia",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Pulmonary complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diffuse infiltrates",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Intestinal effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Upper GI symptoms",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mild enterocolitis",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Severe enterocolitis",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Liver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cholestatic jaundice",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatocellular effects",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Pancreas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pancreatitis",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Nervous system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Peripheral/cranial neuropathies",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Encephalopathy",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Eye",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Corneal or lens chrysiasis",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Conjunctivitis",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Iritis/corneal ulcer",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Unknown",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Miscellaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Metallic taste",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"       <td>",
"        Common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Headaches",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Reported in hypertensives on angiotensin converting enzyme inhibitors",
"     <br>",
"      &bull; Possible relationship with HLA-DR3",
"      <br>",
"       &Delta; Proven relationship with HLA-DR3",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14222=[""].join("\n");
var outline_f13_56_14222=null;
var title_f13_56_14223="Immunization resources";
var content_f13_56_14223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82687&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Online resources regarding vaccines and vaccine safety",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Organization/URL",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Professional organizations/societies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         American Academy of Family Physicians",
"        </p>",
"        <p>",
"         <a href=\"file://www.familydoctor.org\" target=\"_blank\">",
"          www.familydoctor.org",
"         </a>",
"         (search on \"vaccines\")",
"        </p>",
"       </td>",
"       <td>",
"        Patient information on childhood vaccines (what they are and why children need them)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         American Academy of Pediatrics Childhood Immunization Support Program",
"        </p>",
"        <p>",
"         <a href=\"file://www.aap.org/immunization\" target=\"_blank\">",
"          www.aap.org/immunization",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Compilation of resources for families and providers, including Q&amp;A for families and information on vaccine-preventable illnesses, vaccine ingredients, vaccine safety, and the immunization schedule",
"        </p>",
"        <p>",
"         Provides information for clinicians on how to communicate with parents about immunization, including responses for common reasons for parental refusal to vaccinate",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Canadian Pediatric Society",
"        </p>",
"        <p>",
"         <a href=\"file://www.caringforkids.cps.ca/\" target=\"_blank\">",
"          www.caringforkids.cps.ca/",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides a parent's guide to immunization information on the Internet",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Infectious Diseases Society of America (IDSA)",
"        </p>",
"        <p>",
"         <a href=\"file://www.idsociety.org\" target=\"_blank\">",
"          www.idsociety.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides lists of resources, IDSA position statements, and policy statements",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Group on Immunization Education, Society of Teachers and Family",
"        </p>",
"        <p>",
"         <a href=\"file://www.immunizationed.org\" target=\"_blank\">",
"          www.immunizationed.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides links to immunization information and resources, including an audio-recording of the pertussis cough in an infant",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Academic institutions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Center for Vaccine Awareness and Research, Texas Children's Hospital",
"        </p>",
"        <p>",
"         <a href=\"file://www.vaccine.texaschildrens.org\" target=\"_blank\">",
"          www.vaccine.texaschildrens.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides valuable information regarding vaccination. Includes links to resources, including a book that profiles families devastated by vaccine-preventable illness (for purchase).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Institute for Vaccine Safety, Johns Hopkins University",
"        </p>",
"        <p>",
"         <a href=\"file://www.vaccinesafety.edu\" target=\"_blank\">",
"          www.vaccinesafety.edu",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides an independent assessment of vaccines and vaccine safety to guide decision makers and educate physicians, the public, and the media about the safety of vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         The Nemours Foundation KidsHealth",
"        </p>",
"        <p>",
"         <a href=\"file://kidshealth.org/teen/your_body/health_basics/immunizations.html\" target=\"_blank\">",
"          kidshealth.org/teen/your_body/health_basics/immunizations.html",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Vaccine information targeted to adolescents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         The Vaccine Education Center at the Children's Hospital of Philadelphia",
"        </p>",
"        <p>",
"         <a href=\"file://www.vaccine.chop.edu\" target=\"_blank\">",
"          www.vaccine.chop.edu",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides reliable information about vaccines to parents and healthcare professionals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Public health/advocacy groups",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Allied Vaccine Group",
"        </p>",
"        <p>",
"         <a href=\"file://www.vaccine.org\" target=\"_blank\">",
"          www.vaccine.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Links to Web sites dedicated to presenting valid scientific information about vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Program for Appropriate Technology in Health (PATH) Vaccine Resource Library",
"        </p>",
"        <p>",
"         <a href=\"file://www.path.org/vaccineresources/\" target=\"_blank\">",
"          www.path.org/vaccineresources/",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Offers a variety of high-quality, scientifically accurate documents and links to information about vaccine-preventable diseases and vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Every Child by Two",
"        </p>",
"        <p>",
"         <a href=\"file://www.ecbt.org\" target=\"_blank\">",
"          www.ecbt.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Seeks to raise parental awareness of the need for timely infant immunizations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Health on the Net Foundation",
"        </p>",
"        <p>",
"         <a href=\"file://www.hon.ch\" target=\"_blank\">",
"          www.hon.ch",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Nonprofit, nongovernmental organization that promotes and guides the deployment of useful and reliable online health information",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Immunization Action Coalition (IAC)",
"        </p>",
"        <p>",
"         <a href=\"file://www.immunize.org\" target=\"_blank\">",
"          www.immunize.org",
"         </a>",
"         (search on \"immunization safety\")",
"        </p>",
"       </td>",
"       <td>",
"        The IAC creates and distributes educational materials and facilitates communication about the safety, efficacy, and use of vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Institute of Medicine (IOM)",
"        </p>",
"        <p>",
"         <a href=\"file://www.iom.edu\" target=\"_blank\">",
"          www.iom.edu",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Independent, nonprofit organization that works outside the government to provide unbiased and authoritative advice. Provides access to the IOM immunization safety reviews (eg, vaccines and autism, multiple immunizations and immune dysfunction, etc).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         National Alliance for Hispanic Health",
"        </p>",
"        <p>",
"         <a href=\"file://www.hispanichealth.org\" target=\"_blank\">",
"          www.hispanichealth.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Advocacy and research forum focused on Hispanic health and well-being. Provides links to information about vaccine-preventable disease and other health issues.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         National Foundation for Infectious Diseases",
"        </p>",
"        <p>",
"         <a href=\"file://www.nfid.org\" target=\"_blank\">",
"          www.nfid.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Nonprofit organization dedicated to educating the public and healthcare professionals about the causes, treatment, and prevention of infectious diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         National Meningitis Association",
"        </p>",
"        <p>",
"         <a href=\"file://www.nmaus.org\" target=\"_blank\">",
"          www.nmaus.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Nonprofit organization founded by parents whose children have died or have permanent disability from meningococcal disease. Includes links to educational materials, including a video featuring the stories of meningococcal disease survivors and families affected by the disease.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         National Network for Immunization Information",
"        </p>",
"        <p>",
"         <a href=\"file://www.immunizationinfo.org\" target=\"_blank\">",
"          www.immunizationinfo.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides science-based information to individuals who need to know the facts about immunization. Publishes a booklet with tips on how to find reliable immunization information on the Internet (for purchase).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         The Vaccine Page",
"        </p>",
"        <p>",
"         <a href=\"file://www.vaccines.org\" target=\"_blank\">",
"          www.vaccines.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides access to news about vaccines and annotated database of vaccine resources on the Internet; the vaccine page does not control the content of the news links and encourages readers to validate the news items through reputable resources (eg, the Allied Vaccine Group)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         World Health Organization",
"        </p>",
"        <p>",
"         <a href=\"file://www.who.int/topics/vaccines/en/\" target=\"_blank\">",
"          www.who.int/topics/vaccines/en/",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides links to information about immunization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Vaccine Information You Need",
"        </p>",
"        <a href=\"file://www.vaccineinformation.org/\" target=\"_blank\">",
"         www.vaccineinformation.org",
"        </a>",
"       </td>",
"       <td>",
"        Provides information about vaccines and the diseases they prevent, including a video library",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Parent/family groups",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Families Fighting Flu",
"        </p>",
"        <p>",
"         <a href=\"file://www.familiesfightingflu.org\" target=\"_blank\">",
"          www.familiesfightingflu.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Nonprofit corporation dedicated to educating people about the severity of influenza and the importance of vaccinating children against the flu",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Parents of Kids with Infectious Diseases",
"        </p>",
"        <p>",
"         <a href=\"file://www.pkids.org/immunizations.php\" target=\"_blank\">",
"          www.pkids.org/immunizations.php",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides links to information about vaccines and vaccine safety",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Meningitis Angels",
"        </p>",
"        <p>",
"         <a href=\"file://www.meningitis-angels.org\" target=\"_blank\">",
"          www.meningitis-angels.org",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides education about bacterial meningitis and prevention of bacterial meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Government agencies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         United States Centers for Disease Control and Prevention",
"        </p>",
"        <p>",
"         <a href=\"file://www.cdc.gov/vaccines\" target=\"_blank\">",
"          www.cdc.gov/vaccines",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information and links about vaccines and vaccine-preventable diseases",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         US Food and Drug Administration",
"        </p>",
"        <p>",
"         <a href=\"file://www.fda.gov/cber/vaccines.htm\" target=\"_blank\">",
"          www.fda.gov/cber/vaccines.htm",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information about vaccines licensed in the United States and information about vaccine safety, including consumer updates",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         National Institute of Allergy and Infectious Diseases",
"        </p>",
"        <p>",
"         <a href=\"file://www3.niaid.nih.gov/topics/vaccines/\" target=\"_blank\">",
"          www3.niaid.nih.gov/topics/vaccines/",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Provides information about understanding vaccines, community immunity, and vaccine research",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Miscellaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Baby 411",
"        </p>",
"        <p>",
"         <a href=\"file://www.windsorpeak.com/baby411/\" target=\"_blank\">",
"          www.windsorpeak.com/baby411/",
"         </a>",
"        </p>",
"       </td>",
"       <td>",
"        Link to free excerpt on vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Books",
"       </td>",
"       <td class=\"subtitle2_left\">",
"        Publisher",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Immunizations and Infectious Diseases: An Informed Parent's Guide",
"        </em>",
"        by Fisher MC",
"       </td>",
"       <td>",
"        American Academy of Pediatrics, Elk Grove Village, IL 2005",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Vaccinating Your Child: Questions and Answers for the Concerned Parent",
"        </em>",
"        by Humiston SG, Good C",
"       </td>",
"       <td>",
"        Peachtree Publishers, Atlanta 2000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Do Vaccines Cause That? A guide for Evaluating Vaccine Safety Concerns",
"        </em>",
"        by Myers MG, Pineda D",
"       </td>",
"       <td>",
"        Immunizations for Public Health 2008",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Vaccines: What Every Parent Should Know",
"        </em>",
"        by Offit PA, Bell LM",
"       </td>",
"       <td>",
"        IDG Books, New York 1999",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <em>",
"         Autism's False Prophets: bad science, risky medicine, and the search for a cure",
"        </em>",
"        by Offit PA",
"       </td>",
"       <td>",
"        Columbia University Press, New York 2008",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from:",
"     <br/>",
"     <ol>",
"      <li>",
"       American Academy of Pediatrics. Sources of vaccine information. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.3.",
"      </li>",
"      <li>",
"       Pickering LK, Baker CJ, Freed GL, et al. Immunization programs for infants, children, adolescents, and adults: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49:817.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_56_14223=[""].join("\n");
var outline_f13_56_14223=null;
